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ABSTRACT
Much evidence has been accumulated that suggest a link between the phenomenon of 
multidrug resistance (MDR) and the resistance to oxidative stress. Most of these studies 
have been performed in tumour cells exhibiting MDR phenotype and usually demonstrate 
that the development of MDR renders the tumour cells resistant to oxidizing agents such 
as hydrogen peroxide (H2O2) or ultraviolet A (UVA, 320-400nm). However to date, no 
study have revealed the underlying mechanism involved. In this thesis, we used a cell 
model composed of two human Jurkat T cell lines of parental and H2O2 resistant to assess 
the pathways behind cellular resistance to oxidative stress and the possible link between 
the development of MDR phenotype and resistance of cells to the oxidising agents.
To this regard, both parental and H2O2 resistant cells were first characterised in terms 
of the level of susceptibility to oxidizing agents H2O2 and UVA and then the involvement 
of intracellular antioxidant defence and labile iron was investigated. Resistance of cells to 
H2O2 was confirmed and our data revealed that necrosis is the primary mode of cell death 
induced by both H2O2 and UVA. The characterisation of antioxidant defence mechanism 
in these cell lines revealed that resistance of cells to H2O2 is mainly due to higher 
glutathione peroxidase (GPx) activity. Furthermore both higher intracellular levels of 
glutathione (GSH), ferritin (Ft) and heme-oxygenase 1 (HO-1) appeared to contribute to 
higher H2O2 resistance of H2O2 resistant Jurkat cells.
Since exposure of skin cells to UVA or H2O2 has been shown to cause an immediate 
increase in intracellular labile iron pool (LIP), we sought to monitor both the ‘basal’ and 
‘oxidant-induced’ increase in LIP following exposure of cell lines to both UVA and H2O2 
insults. The results revealed that although the ‘basal’ level of LIP in both parental and 
H2O2 resistant cell lines was similar, the H2C>2-induced level of labile iron release was 
much higher in parental cells than in H2O2 resistant cell line. This finding strongly 
suggested that cellular resistance to H2O2 is tightly associated to intracellular level of LIP 
and that the “induced” rather than the “basal” level of labile iron is responsible for the 
increased susceptibility of cells to oxidative stress.
Ill
Interestingly, the exposure of both parental and H2O2 resistant cells to UVA promoted 
both similar level of labile iron releases and percentage survival consistent with the 
notion that H2O2 and UVA should exert their effect on cells via different oxidant 
mechanism.
Subsequently, an attempt was made to correlate the level of FLCVinduced iron 
release and the extent of cell damage following oxidative treatment. For this purpose, 
cells were treated either with Desferal (DFO) or hemin (iron loading) prior to a range of 
doses of H2O2. The DFO treatment of normal and H2O2 resistant cells completely 
abolished both the ‘basal’ and ‘induced’ level of LIP and protected cells against H2O2- 
mediated damage. Interestingly hemin pre-treatment dramatically decreased the H2O2- 
induced level of labile iron release in the parental cells, while increasing the level of 
H202-induced labile iron release in H2O2 resistant cells. Furthermore, hemin pre­
treatment protected the parental cells against H202-induced necrotic cell death, but 
sensitises H2O2 resistant cells to the cytotoxic effect of H2O2. The differential response 
of hemin treatment in both parental and H2O2 resistant cells highlighted the crucial 
importance of oxidant-induced labile iron release in the increased susceptibility of cells to 
oxidative damage.
Finally, we could not establish any link between MDR and resistance to H2O2, since 
both parental and H2O2 resistant cells appeared to have similar drug efflux activity of PgP 
function and no genes responsible for the MDR phenotype (mdr-1, mrp and mxr) was 
detected in either cell line.
In summary these data provide the first direct evidence for association of intracellular 
level of LIP and the resistance of cells to oxidative damage and suggest pathways for 
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It has been recognised more than a hundred years ago that oxygen (O2), the breath of 
life, apart from being beneficial can be also toxic to all living organisms. Except for 
certain anaerobic and aerotolerant unicellular organisms, O2 is required for efficient 
production of energy by the use of 02-dependent electron transport chains. However, 
when O2 is supplied at concentrations greater than normal it can be toxic to all living 
organisms. Nowadays, it is known that both beneficial and damaging effects of O2, are 
caused by the same types of reactive oxygen species (ROS).
Reactive oxygen species is a collective term that includes not only the oxygen 
radicals (i.e. superoxide (O*- ) and hydroxyl (O ff)) but also some non-radical derivatives 
such as singlet oxygen ( ^ 2), hydrogen peroxide (H2O2) and ozone (O3), which are 
capable o f forming radicals. An elevation in the cell by a steady state concentration of a 
variety of ROS results in an imbalance between the mechanisms triggering oxidative 
conditions and the cellular anti-oxidant defences. This characterizes a phenomenon 
termed “oxidative stress”. Potentially dangerous oxygen-linked damaging processes are 
thought to form the basis of a number of physiological and pathophysiological events
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such as inflammation, ageing, carcinogenesis, drug action, drug toxicity and more 
recently programmed cell death.
1.1.1 Reactive oxygen species (ROS)
Both exogenous (i.e. xenobiotics, ozone, photochemical smog, ultraviolet light, 
ionising radiation), as well as endogenous (i.e. mitochondrial respiration, phagocytic 
oxidative burst) processes can generate highly reactive compounds known as radicals. 
Here discussion will be focused on the exogenous processes that can generate ROS and in 
particular ultraviolet A (UVA) and H2O2.
A free radical is defined as “atom or molecule with one or more unpaired electrons in 
an orbital in the outermost electron shell”. Free radicals are capable of independent 
existence and are able to donate or take an electron from an impaired electron to another 
molecule, generating another radical by chain reaction, which enhances the initial 
damage. The primary target of free radicals is the lipid bilayer of the membrane. 
However, free radicals can also oxidize protein, lipid and carbohydrate.
Molecular O2 has two unpaired electrons in a parallel spin and can be a powerful 
oxidizing agent, since it can easily absorb electrons from surrounding molecules. 
However, if O2 attempts to oxidize another atom or molecule by accepting a pair of 
electrons from it, both of these electrons would be of antiparallel spin and according to 
Pauli’s principle wouldn’t fit in the n* orbitals of O2. This imposes a restriction on 
electron transfer, which tends to make O2 accept its electrons one at a time. For example, 
reduction of O2 to water (H2O) requires a series of four one-electron-uptake steps, which
2
involves a series of ROS, as shown in Figure 1.1. This process makes O2 react with 
biomolecules poorly, unless a transition metal such as iron is present as a catalyst.
O 2  +  Q  ^  O 2
O2” + e ' + 2H+ ----------► H2O2
H2O2 + e + H+  ► h 2o  + OH*
OH* + e' + H+ ^  H20
Figure 1.1: The series of ROS emerging from the step by step reduction of O2 to H2O, 
involving 4-electron (e ) reduction.
The first product of an electron reduction of O2 molecule yields the Cff • Production 
of seems to occur within all aerobic cells and more specific in the endoplasmic 
reticulum and during respiration (electron transport chains of mitochondria). Microsomal 
fractions containing endoplasmic reticulum have been shown to produce C f  via NADPH 
oxidase enzymatic system. At physiological O2 levels, it has been suggested that about 1- 
3% of the O2 reduced in mitochondria may form 0 *2~, depending on intra-mitochondrial 
O2 concentrations. Superoxide anion is not readily reactive towards most biomolecules, 
including lipids and nucleic acids (Fridovich, 1978). However, it may react with certain 
proteins and inactivate them, especially proteins in the presence of transition metals 
prosthetic groups such as heme moieties or iron-sulphur clusters (Gardner et al, 1995). 
As a consequence, 0 *2~ toxicity is highly dependent on the availability of iron in the 
system.
The most important reaction of C ff is the dismutation reaction which produces the 
well known oxidant H2O2. This reaction can occur either spontaneously or via catalysis
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by a group of enzymes, the superoxide dismutases (SOD). H2O2 is only a weak oxidizing 
and reducing agent and is generally poorly reactive, but in the presence of transition 
metals, it is capable of inactivating proteins via oxidation o f essential thiol (-SH) groups 
or proteins containing iron-sulphur (Fe-S) clusters, reduced heme moieties or copper 
prosthetic groups. Most of the damaging effects of H2O2 are thought to be the result of 
the formation of OH* (see also section 1.2.2). Unlike O2" , H2O2 crosses membranes 
readily and can therefore migrates within the cell and extends cellular damage. The 
biological importance o f H2O2 also arises from its ability to diffuse through hydrophobic 
membranes. Hydrogen peroxide has also been found to be generated after UVA radiation 
(see section 1.3).
Hydroxyl radical (OH*) is the most reactive of all oxygen radicals and will readily 
oxidize lipids, proteins, carbohydrates and nucleic acids. The importance of OH* as an 
oxidant in biological systems was first suggested when it was shown to be generated by 
X-ray irradiation. The OH* is the product of Fenton reaction involving H2O2 and reduced 
iron (see also section 1.2 .2).
1.1.2 Iron and reactive oxygen species (ROS)
The cytotoxic actions of ROS are increased in the presence of a transition metal 
catalyst, with iron being the most abundant transition metal. The ability of this transition 
metal to exist in two redox states makes it useful at the catalytic centre of fundamental 
biochemical reactions. Iron can react with O2 and H2O2, giving rise to a highly reactive 
OH* radical via the Haber-Weiss or Fenton reaction (Aust et al, 1985, Halliwell and 
Gutteridge 1999), respectively. The Haber-Weiss reaction is shown below:
4
or + H20 2 0 2 + H20  + OH
The Fenton reaction is usually written:
Fe2+ + H20 2 -----► OH" + OH' + Fe3+
Fenton chemistry is a prime example of a damaging free radical reaction that is catalysed 
by iron (Fe2+) and the best characterised is the generating OH*.
However, in cells the true catalyst of Fenton reaction is more likely to be the low- 
molecular mass (LMrFe) free iron pool or iron made available from other cellular sources 
under conditions of oxidative stress. This pool provides the cell with a relatively 
accessible form of iron for incorporation into cytosolic enzymes and proteins. When 
present in extracellular compartments has been found to be associated with ligands such 
as citrate, acetate, and phosphate, and also with ATP, GTP, pyrophosphates and amino 
acids (reviewed by Symons and Gutteridge, 1998). The amount of iron within this pool is 
dependent on the type of cell, with values ranging from 0.2 to 1.5 pM (Epsztejn et al,
1997) and is probably present in the ferrous state. The iron which can be extracted from 
proteins by ligands into LMrFe form has been termed the “labile iron pool” (LIP) by 
Jacobs in 1977 and White in 1976 (see section 1.2.2).
1.2 Iron
1.2.1 General aspects
Elemental iron is essential for normal cell growth and proliferation, and is required by 
almost every organism. Living organisms, from bacteria to mammals, appear to have
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selected iron for achieving a large number of essential biological processes in which is 
involved as part of or as a metal cofactor for many proteins and enzymes, either nonheme 
or hemoproteins (Aisen and Listowsky, 1980).
In the adult human body the largest pool of iron (about 75%) is present in heme, 
mainly found in hemoglobin and myoglobin, which transport oxygen. Most O2 carried in 
the blood is transported by hemoglobin. The hemoglobin molecule has four protein 
subunits, two a-chains and two p-chains. Each chain carries a heme group with iron in
2+ 2+
the Fe state. Only the ferrous iron form (Fe ) of hemoglobin can bind O2, permitting 
efficient energy production and allowing the operation of enzymes that catalyse 
metabolic transformations. Heme can be synthesised in mammalian cells and by many 
bacteria. Figure 1.2 illustrates a diagrammatic representation of the heme synthesis 
pathway. The heme biosynthetic pathway is probably identical in all mammalian cells 
and involves eight enzymes, four of which are cytoplasmic and four of which are 
localised in the mitochondria. In brief, heme synthesis is mainly catalysed by the 
enzymes coporphyrinogen oxidase (in the cytosol) and protoporphyrinogen oxidase (in 
the mitochondria). The first step occurs in the mitochondria and involves the 
condensation of succinyl Co A and glycine to form 5-aminolevulinic acid (ALA). The 
next four steps take place in the cytosol. The final three steps occur in the mitochondria 
and involve the insertion of ferrous iron into photoporphyrin IX by ferrochelatase and 
finally the production of heme (reviewed by Ponka, 1997). Heme biosynthesis is 
normally remarkably efficient.
Besides hemoglobin, other hemoproteins include: (a) cytochromes, which are present 
in mitochondria and required for the electron chain reactions; (b) catalase and peroxidase,
6
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Figurel.2: Diagrammatic representation o f heme synthesis in mammalian cells.
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which react with H2O2 and protect against uncontrolled cellular oxidation (section 1.6); 
and (c) tryptophan oxygenase, which is used for intermediary metabolism and catalyses 
conversion of tryptophan to N-formylkymeremine, using O2 as the oxidant (section 1.4).
Around 10% of the total iron is required for numerous metalloenzymes and 15% is 
present in the iron-storage protein, ferritin (Ft). These iron-complexing molecules leave 
body fluids and cells with extremely low concentration of “free” transit iron. 
Nevertheless there is now strong evidence of a pool of catalytically active “free” iron 
known as labile iron pool (LIP). The LIP exists within cells at a concentration of 0.1-1 
jliM  and is accessible to permeant chelators. This pool of reactive iron is known to be 
potentially harmful, since it can catalyse the formation of ROS such as OH*and lipid- 
derived alkoxyl and peroxyl radicals (see section 1.2.2). Therefore, balancing 
intracellular iron is essential for survival of the cells (see section 1.3).
1.2.2 Labile iron pool (LIP)
The metabolically active forms of intracellular iron are components of cytosolic LIP, 
also referred to as chelatable iron pool (Jacobs, 1977). It contains the metabolically and 
catalytically reactive iron of the cells. Labile iron pool is associated with important 
functions: (a) physiologically, as readily available sources of iron for incorporation into 
proteins; (b) pharmacologically, as targets for chelators or metal scavengers; and (c) 
toxicologically, as vehicles for promoting the formation of free radicals.
The LIP provides the cell with a relatively accessible form of iron for incorporation 
into cytosolic enzymes or proteins (Breuer et al, 1996). Although, the nature of the LIP is 
not fully characterised, there are several observations (see Harrison and Arosio, 1996),
94- 4^-suggesting that it consists of both ferrous (Fe ) and ferric (Fe ) ligands. Labile iron pool 
exists in dynamic equilibrium as Fe2+ and Fe3+ forms, which is mainly controlled within 
ferritin (Ft) where Fe is deposited after oxidation of the Fe form.
Unlike Ft bound iron, the LIP is loosely bound to macromolecular complexes and 
they are sensed by the cytosolic iron regulatory proteins (IRPs). The LIP is maintained by 
a balanced movement of iron from extracellular and intracellular sources, which can be 
increased by endocytosis of transferrin (Tf) bound iron or non-Tf bound iron and 
degradation of Ft (see section 1.3).
In general, all aspects of intracellular homeostasis are monitored by the LIP, since it 
is rapidly transmitted through the cell and constitutes a real turning point of metabolic 
pathways of iron-containing compounds.
In contrast to the intracellular LIP, there is also the presence of the extracellular LIP, 
which is often associated with pathological conditions. This form of LIP has been 
originally observed in iron-over-loaded thalassemia patients whose plasma Tf iron- 
binding capacity was surpassed (Hershko et al, 1978). In addition, to thalassemia, other 
conditions of iron imbalance have been defined (i.e. hemochromatosis (HH)), in which 
the LIP has been found to be bound to ligands other than Tf or non-Tf bound iron. Finally 
there is evidence for age-related accumulation of LIP associated with rheumatoid arthritis 
(Guillen et al, 1998).
Primarily, attempts to quantify and assess the LIP relied on methods that involved 
homogenisation of the cells and tissue, and iron content was then determined using 
electron paramagnetic resonance with iron chelators (Kozlov et al, 1992) or DFO- 
chelatable 59Fe (Rothman et al, 1992). However, cell or tissue homogenisation required
9
cell disruption that could alter the equilibrium between free and bound iron as well as its 
oxidation state. Therefore, detection of LIP has necessitated the development of distinct 
probes.
Among the different approaches developed for analysing LIP, those based on the 
selective interaction of LIP with iron chelators provide the simplest and most accessible 
tools. Indeed, fluorescence detection of iron on probes or metal-sensing molecules that 
undergo swift changes in signal properties as a result of an interaction with labile iron has 
been a favoured approach for the estimation of LIP. Cabantchick and co-workers in 1997 
have developed one of the most efficient fluorescent assays, called the fluorescent calcein 
assay (CA-assay) (see section 2.7). Calcein is a fluorescent probe that binds readily, 
stoichiometrically (1:1) and reversibly with a fraction of Fe2+ associated with LIP, while 
forming fluorescent quenched CA-bound iron complexes (CA-Fe). Consequently, the 
quenched fluorescence of the CA-Fe complex in solution can be fully restored by 
addition of excess chelators such as salicyladedehyde isonicotinoyl hydrazone (SIH) 
which can abstract iron from CA. Thus, the CA fluorescence assay is based on the 
availability of fast permeating high affinity chelators, with SIH being the best candidate
l 3~f 29 1since it can chelate Fe and Fe forms of iron and has a binding constant 10 M' for 
Fe3+ and 1020 M ' 1 for Fe2+ (Tsakack et al, 1996 and Epsztejn et al, 1997). After the 
development of this assay, a number of different studies were carried out to assess 
changes in the LIP after various treatments.
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1.3 Iron Homeostasis
Mammalian cells maintain constant levels of metabolically active iron through the 
regulation of iron uptake and storage. The pathway of iron uptake via transferrin receptor 
(TfR) and the iron storage in Ft are co-ordinately regulated at the post-transcriptional 
level by cytoplasmic factors known as IRPs. These regulatory mechanisms operate in 
order to prevent the expansion of the intracellular LIP, but still secure adequate supply of 
iron for the synthesis of iron-dependent proteins. Although, there is a widespread 
agreement that these regulatory mechanisms are utilised in many cell types, additional 
regulatory pathways may operate in erythroid cells due to their specialised function in 
hemoglobin synthesis (see section 7.3.3).
7.3.7 Transferrin (Tf)
Transferrin belongs to a family of related-binding proteins that includes:(a) 
lactoferrin, which is found both intracellularly and in secretions such as milk, tears and 
semen; (b) ovotransferrin, which is present in egg white and (c) melanotransferrin, which 
is formally known as tumour antigen p97. These proteins share a high degree of sequence 
homology and their molecular weight is around 80 kDa. Transferrin is the plasma iron- 
binding glycoprotein and functions as the major vehicle for transfer of iron in the body 
between sites of absorption, storage and use. It is normally the only source of iron for 
hemoglobin synthesis. Transferrin has a high affinity for Fe (K<j = 1 0 ' mol/L) and only 
one Fe3+ attaches to each of one of the two globular domains extremely tight at 
physiological pH. Transferrin exists as a mixture of iron-free (apoTf), one iron (monoTf) 
and two iron (difericTf) forms of the molecule. The primary function of Tf is to accept
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iron from plasma and to transport iron into various cells and tissues, by binding to 
membrane receptors (Tf-receptors, see below), internalise iron via endocytosis and finally 
release its iron at acidic pH in late endosomes (Figure 1.3).
Transferrin receptors (TfRs) provide for controlled access of Tf to the cells. There are 
two forms of TfR, TfRl and TfR2, which have distinct cell- and tissue- specific pattern. 
However, TfR2 has only been described in 1999 in liver, liver-derived and human 
erythroleukemia K562 cell lines, so TfRl has been the most studied one and was simply 
designated the TfR. Transferrin receptor is expressed in all cell types apart from mature 
erythrocytes and other terminally differentiated cells. It is comprised of two disulfide- 
bonded identical 90 kDa subunits and is far more abundant than TfR2. Transferrin binds 
to the TfR at the cell surface and is internalised through clathrin-coated pits into 
endosomes (Figure 1.3). At the acidic pH of the endosome, iron dissociates from Tf and 
is taken to the cytoplasm via membrane transporters (i.e. DMT-1 and H-ATPase). Once 
the iron has passed through the membrane it enters the intracellular LIP compartment. 
The iron now inside the cell can be used for metabolic functioning (modulation of the 
IRPs activity) can be taken up by mitochondria or can be stored in Ft (Figure 1.3). After 
the return of the receptor to the cell surface, the extracellular pH triggers the release of 
apo-Tf, allowing another round of binding and endocytosis to begin. Thus Tf may protect 
cells against oxidative damage by binding to iron and preventing oxidative reactions 














Figure 1.3: Diagrammatic representation o f the uptake o f transferrin-mediated iron transport into cells 
(Adapted from Aisen et al, 2001).
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1.3.2 Iron regulatory proteins URPs)
The level of LIP is thought to be both sensed and homeostatically controlled by IRP- 
1 and IRP-2, which function as regulators of iron uptake and distribution processes within 
cells, and co-ordinately regulate the expression of the transferrin receptor (TfR) and of Ft. 
Iron regulatory protein-1 resembles mitochondrial aconitase in sequence, it can assemble 
an iron-sulfur cluster and is enzymatically active (Kaptain et al, 1991). So, activation of 
IRP-1 involves an iron-sulphur cluster, which depending on its iron content, acts either as 
an RNA-binding protein or as a cytoplasmic aconitase (Kuhn, 1994). For example:
(3Fe -  4S)+ + Fe2+ ► (4 F e-4 S )2+
Unlike IRP1, IRP2 does not show any aconitase activity, nor does it accumulate an iron- 
sulphur cluster. It appears to be regulated by proteasome-mediated degradation.
Indeed, the stem-loop structures, called iron responsive elements (IREs), which are 
present in the respective mRNAs of genes of the iron-storage (Ft) and iron-uptake (TfR) 
proteins, interact with the cytosolic ERPs and regulate the level of LIP in the cells. In 
particular, an increase in reactive labile iron in the cells will cause inactivation of IRP-1 
(90 kDa) and degradation of IRP-2 (105 kDa), leading to the induction of Ft mRNA 
translation and degradation of TfR mRNA. The resulting de novo synthesised Ft protein 
will sequester the excess iron resulting in a decreased level of intracellular labile iron 
(Figure 1.4). In contrast, an iron deficiency leads to the binding of IRPs to IREs resulting 
to inhibition of Ft mRNA translation and induction of TfR protein synthesis (Figure 1.4). 




















Ft mRNA translation is blocked TfR mRNA translation
Labile iron pool increases
gure 1.4: Diagrammatic representation o f the coordinated regulation o f iron uptake and storage at posttranslational 
/el (Adapted from Henderson et al, 1996).
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suggested that TfR2 is most probably regulated by the cell cycle accommodating the 
needs of cell proliferation, since it is over-expressed in the iron-overloaded liver of HH 
(Fleming et al, 2000 and Kawabata et al, 2000).
The action of IRP proteins can be further modulated through the activation of signal 
transduction cascades, like protein kinase C (PKC) which when activated phosphorylates 
either IRP1 or ERP2 through different serine residues and increases IRP1/IRP2 binding to 
the IRE (Schalinske and Eisenstein, 1996).
Other proteins that process stem-loop structures either on the 5’ or 3’ untranslated 
portion of their mRNA include erythroid 5-amino levulinic acid synthase (ALA-synthase, 
see section 1.2.1) which is involved in heme biosynthesis (Gardner et al, 1991), 
mitochondrial aconitase (Dandekar et al, 1991) and DMT-1 (reviewed by Sheth and 
Brittemham, 2000). Additional IRE sequences have also been identified in ferroportinl 
(Donovan et al, 2000) and IREG1 (McKie et al, 2000) which plays a role in iron efflux 
across membranes to plasma but their function in IRP binding has not yet been 
determined.
An important finding correlating IRP and 5-ALA was also observed by Pourzand et 
al in 1999a. They demonstrated that there is a strict dependence on enhancement on LIP 
levels by photoporphyrin IX (PPIX) and the level of IRP activation. They proposed that 
the level of IRP activation could serve as a better marker for iron deficiencies than TfR 
expression since is directly correlated with the level of intracellular LIP.
Finally, relative ratios of IRP1/IRP2 differ between tissues with IRP1 being the 
highest in liver, kidney, intestine and brain, and the least abundant in pituitary and pro-B- 
lymphocytic cell lines (Thomson et al, 1999).
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1.3.3 Ferritin (TO
An additional mode of regulation of LIP operates through the Ft molecule. It is 
generally accepted that increased cellular iron levels appear initially in the LIP, but the 
excess iron is sequestered into Ft molecules (Piccard et al, 1998).
Indeed, most of the iron that is not metabolised is stored in Ft. Ferritin is the major 
iron storage protein. It is ubiquitous in mammalian cells and is tightly regulated by IRPs. 
Holoferritin can accommodate approximately 4,500 atoms of iron, doubling its molecular 
mass to 900 kDa. This protein forms a hetero-oligomeric protein shell composed of a 
light- (L, 19kDa) and heavy- (H, 21 kDa) chain subunits (Munro and Linder, 1978; Theil,
I q  j
1987). The heavy chain of Ft has ferroxidase activity, which oxidises Fe to Fe for iron 
uptake by the Ft molecule. The H-Ft has a high affinity for Fe3+ (IQ = 10'25 mol/L). Iron
*5 i
storage in the ferric form (Fe ) protects iron from reduction (Balia et al, 1992). In 
contrast, the L-Ft chain has no ferroxidase activity, but has a nucleation site that 
facilitates iron core formation within the cell and has more iron storage capacity. The H- 
to-L ratio is not fixed but is readily modified in response to different stimuli such as 
inflammation and stress, promoting the cell to adjust to changes in iron metabolism. For 
example, an increase in the proportion of the L-Ft is associated with iron storage, whereas 
the H-Ft is more abundant when iron is needed for cellular metabolism. The role of iron 
in controlling the amount of Ft in mammalian cells is mostly via the regulation of Ft 
synthesis at a translation step (section 1.5.2).
Small quantities of Ft are also present in human serum and are elevated in conditions 
o f iron overload and inflammation (Torti and Torti, 1994). It is generally believed that 
serum Ft has a low iron content (roughly each jug/L Ft corresponds to 8mg storage iron)
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even in iron over-loaded individuals (Linder et al, 1996). In 1995, Beaumont and co­
workers identified a new genetic disorder in which patients with increased levels of 
serum Ft present early onset cataract. This genetic syndrome is due to mutation on the L- 
Ft gene located on chromosome 19ql3.3 and is believed that cataract is a consequence of 
excessive L-Ft production. However, the exact mechanism underlying the latter has not 
yet been identified. Moreover, iron overloaded cells, in conditions such as HH, may 
contain another storage form of iron called hemosiderin.
Hemosiderin is a degradation product of Ft since under conditions of iron excess, Ft 
is taken-up by lysosomes where it undergoes a partial dissolution of the core resulting in 
the formation of insoluble hemosiderin (Harrison and Arosio, 1996). Hemosiderin is a 
lipoprotein found in lysosomes, which appears to be a dead end in the metabolism of iron 
and Ft.
Recently, Levi et al (2001) have reported a new Ft gene, the mitochondrial Ft (MtF). 
Mitochondrial Ft is a novel H-type Ft encoded by an intronless gene on chromosome 
5q23.1. It exhibits more than 75% sequence identity to the H-Ft gene and appears to 
sequester iron more avidly than cytosolic H-Fts. Experiments with transfectant cells 
demonstrated that the protein is synthesised as a precursor of about 30 kDa and is 
targeted to mitochondria by a leader sequence of 60 amino acids where is processed into 
a typical Ft shells. Mitochondrial Ft does not appear to be an obligatory intermediate in 
transfer of iron to heme and other iron compounds in mitochondria. Although, iron does 
not normally accumulate in mitochondria, defects in its transport can result in 
mitochondrial iron-loading. Mitochondrial Ft levels show to increase dramatically when 
heme synthesis is inhibited in normal erythroblasts (Levi et al, 2001 and Corsi et al,
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2002). In general, very little is yet known about how iron is delivered to mitochondria 
and whether iron is accessible to MtF. Nevertheless, a study, by Corsi et al (2002) 
showed that in HeLa cells, although the levels of MtF were not increased by exogenous 
iron, when increased by transfection, MtF appeared to retain a high proportion of 
available iron. So iron is potentially as accessible to MtF as it is to cytosolic Ft and 
therefore MtF may provide a new powerful method for regulating cellular iron 
homeostasis.
1.3.4 New genes in iron metabolism
Exciting additions to our understanding of iron homeostasis have come with the 
recent identification of the hemochromatosis protein HFE, the transferring-independent 
transporter Nramp2, the iron exporter ferroprotin land hephaestin.
Hereditary hemochromatosis (HH) is a common autosomal-recessive disorder of iron 
metabolism with an inherited disorder that results from accumulation of excess iron in 
many organs. More than 80% of HH patients have a mutation in a major 
histocompatibility complex (MHC) class I type protein (HFE). The first indication of 
how HFE might regulate iron metabolism came with the discovery that it associates with 
the TfR (Waheed et al, 1999). HFE is a glycoprotein, which associates with 
microglobulin at the cell surface. The mRNA of HFE expression has an IRE and lack of 
HFE expression may be associated with iron overloading, but the exact mechanism by 
which HFE might facilitate iron homeostasis in the body still remains unknown. Recent 
indirect evidence by Riedel et al (1999) implied that HFE expression leads to activation 
of IRPs and results in decreased Ft and iron uptake from diferric Tf in HeLa cells.
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A compelling candidate for endosomal iron transport has been recently identified by 
two groups, Flemming et al (1997) and Gunshin et al (1997). The transporter Nramp2 
(natural resistance-associated macrophage protein) was first identified as a metal 
transporter-1 (DMT1) or divalent cation transporter-1 (DCT1) and is encoded by a gene 
belonging to the Nramp family of genes identified by Collier et al (1995). The mRNA of 
the protein has IREs at its 3’-UTR and is expressed in many different tissues with high 
expression levels at the duodenum brush border. The transporter Nramp2 is located on 
the plasma membrane as well as on subcellular compartments characterised as late 
endosomes or lysosomes. It is generally believed that Nramp2 is subcellulary localised 
with Tf and plays a role in transporting Tf-bound iron from the endosome (see secton
1.3.1 and review by Ponka et al, 2002).
Additional information on iron metabolism has also come with the cloning and 
characterisation of a gene referred to as ferroprotin-l/Ireg-l/MTP-1 (McKie et al, 2000). 
The localisation of ferroprotin-1 in cells and tissues is consistent with its proposed 
function of exporting iron from cells. The ferroprotin-1 mRNA possesses an IRE in the 
5’-UTR. This stem loop structure is similar to other IREs found at the 5’ end of mRNAs 
encoding Ft, 5-ALA synthase and mitochondrial aconitase, suggesting that ferroportin-1 
could be down-regulated under conditions of low intracellular iron. Ferroportin-1 resides 
at the basolateral surface of duodenal enterocytes and may mediate iron efflux across 
membranes to plasma by a mechanism that requires ferroxidase activity (reviewed by 
Roy and Enns, 2000; Lieu et al, 2001).
Finally, sex-linked anaemia (sla) is a disorder that highlights the selectivity of the 
enterocyte basolateral iron transport machinery and emphasises its role in the regulation
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of iron absorption. The protein product of the gene mutated in the sla mouse is the 
hephaestin, which has significant homology to the serum protein ceruloplasmin. 
Ceruloplasmin is a serum multicopper ferroxidase required for efficient iron recycling 
between storage and donation sites (Vulpe et al, 1999). Cloning of hephaestin led to the 
proposal of a role for copper in the transfer of iron from the enterocyte to the plasma.
1.4 Ultraviolet (UV) light
1.4.1 General remarks
At the turn of the 20th century, although many photoreactions were known due to 
exposure of a substrate to (sun)light, the underlying principles were poorly understood. 
Light is a form of electromagnetic radiation that is characterized by its wavelength X (m) 
or its frequency v (c'1), which are linked by the relationship: v = c/X , where c is the speed 
of light (3xl08 ms'1). The first law of photochemistry has been recognised by Grotthus 
(1817) and Draper (1843) who stated, “Only the light absorbed by a molecule can 
produce photochemical change in the molecule”. But, it was not until Planck’s work, in 
1901, that a new relationship was described on the basis of light as being composed of 
packets of energy described as “light quanta” and as “photons” behaving as particles. So, 
the energy per photon (E) is determined by its wavelength as described by the 
relationship: E = h x v  = h x  c/X, where h is Planck’s constant (6.626x1 O'34 Js).
Consequently, Stark and Einstein modified the first law of photochemistry by stating that 
“absorption of radiation by species causes atoms or molecules to get excited through the 
electrons distribution to a higher energy arrangement”. According to these principles, it
21
follows that, the shorter the wavelength, the higher is the energy of the photons of the 
electromagnetic radiation.
The sun continuously emits electromagnetic radiation over a broad range of energies, 
extending from wavelengths shorter than the UV through infrared and radio wavelengths. 
It is primarily the sun’s surface temperature that determines the spectrum of energy it 
radiates. The spectral distribution of solar radiation that reaches the earth’s surface ranges 
between 280 and 400 nm and is subdivided into the UVA (320-400 nm) and UVB (290- 
320 nm) as shown in Figure 1.5. UVA also called “no near-UV” comprises the major 
part (96%) of the total energy of solar UV radiation (Wilkinson, 1983). However, UVB 
also called “mid-UV” accounts for only 4% of solar UV. The third UV component of 
sunlight is UVC (190-290 nm) that does not reach the earth’s surface since it is filtered 
by the stratospheric ozone layer and hence is of negligible intensity. Therefore the effects 
of solar UV radiation on biological systems are only considered in terms of UVA and 
UVB.
The UVB component is directly absorbed by cellular macromolecules including DNA 
and protein leading to DNA photodamage and mutagenesis. In contrast, UVA is weakly 
absorbed by most biomolecules but is oxidative in nature, generating ROS via interaction 
with intracellular chromophores (see section 1.4.3). In this thesis, only UVA that is the 
oxidizing component of sunlight will be discussed.
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1.4.2 Beneficial effects of UV radiation
The sun’s rays provide warmth and light that enhance the general feeling of well­
being and stimulate blood circulation. UV radiation is essential to the body as it 
stimulates the production of vitamin D. Vitamin D is essential for maintaining blood 
calcium levels within a normal and healthy range. Vitamin D is obtained either from the 
diet or by UV radiation of the skin (reviewed by Tyrrell, 1994).
UV radiation has been also used to successfully treat a number o f diseases, including 
rickets, psoriasis, eczema and jaundice. Although, this therapeutic use cannot eliminate 
the negative side effects of UV radiation, treatment takes place only when its benefits 
outweigh the risks.
1.4.3 Ultraviolet A-induced oxidative stress
Ultraviolet (UV) radiation must be absorbed in order to produce a chemical change. 
The first step in a photochemical reaction is the absorption of a single photon by a 
molecule, the chromophore and the production of an excited state in which one electron 
of the absorbing molecule is raised to a higher energy level. Several cellular components 
such as quinones, flavins, steroids and porphyrins are important UVA chromophores. The 
amino acids tyrosine and tryptophan, as well as NADH and NADPH, also exhibit 
absorption within the UVA range.
Evidence from in vitro studies have shown that UVA irradiation is a generator of 
intracellular oxidative stress (Danpure and Tyrrell, 1976; Tyrrell and Pidoux, 1989; 
Tyrrell et al, 1991; Vile and Tyrrell, 1995). These studies demonstrated that singlet
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Figure 1.5: Diagrammatic representation of the ranges ofUV and visible radiation on the surface o f 
the earth (Adapted from Tyrrell, 1994).
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oxygen (’C^) and H2O2 are the most important ROS produced by UVA promoting 
biological damage in exposed tissues. The pathways by which several oxygen species 
may be generated by UVA are shown in Figure 1.6. The most important photolytic 
degradation product of tryptophan is H2O2 and 0*~ Additionally, iron-catalysed reduction 
of H2O2 via either the Haber-Weiss or Fenton reaction can further generate the highly 
reactive OH*. The latter has also been supported by the in vivo studies of Badwey and 
Kamovsky in 1980 on relevant reactions generating 1C>2. The generation of '(>2 after 
UVA treatment has also been supported by studies in human fibroblast cell lines using 
either deuterium oxide (D2O, enhancer of l02 lifetime) or sodium azide (lC>2 quencher) in 
the presence of UVA irradiation. These studies revealed that D2O sensitised cells to UVA 
cytotoxicity whereas sodium azide strongly protected the cells against the lethal action of 
UVA (Tyrrell and Pidoux, 1989). Another important pathway of generation of 
intracelular ROS by UVA radiation involves photo-oxidation of NADH and NADPH (see 
Figure 1.6 and Cunningham et al, 1985). Finally, more recent studies from this 
laboratory using specific scavengers of *02 have clearly demonstrated the involvement of 
]02 in UVA cytotoxicity to mammalian cells (Tyrrell et al, 1991).
Anderson and Parrish in 1981 have confirmed that melanin (complex polymeric 
protein produced by melanocytes) is another important UVA absorbing chromophore in 
human skin. Human melanoma cells with high melanin content have been shown to 
accumulate twice as much oxidative damage upon UVA radiation than cells with low 
melanin content (Kvam and Tyrrell, 1997).
It is now well known that UVA is a strong membrane damaging agent. Several reports 
have demonstrated that UVA irradiation can peroxidize membrane lipids (Putvinsky et al,
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Figure 1.6: Schematic presentation o f the O2 intermediates produced by UVA (Adapted from 
Tyrrell et al, 1991).
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1979 and Azizova et al, 1980). Physiological doses of UVA can induce lipid peroxidation 
(production of alkoxyl radical (LCT), peroxyl radical (LOCf) and lipid peroxide (LOOH)) 
in membranes of human primary fibroblasts and keratinocytes via pathways involving 
iron and ^ 2  (Morliere et al, 1991, Punnomen et al, 1991 and Vile and Tyrrell, 1991).
UVA-induced lipid peroxidation was also found to be dependent on the chemical 
composition of membranes, as polyunsaturated fatty acid enrichment of human 
keratinocytes increased the peroxidation process (Quiec et al, 1995). The UVA-induced 
membrane damage has also been directly correlated with cell death in human skin 
fibroblasts (Applegate et al, 1994). Internal lipid membranes in eukaryotic cells such as 
those of lysosomes, mitochondria and nucleus have also been shown to be damaged 
following UVA radiation (see section 1.7).
Furthermore, other immediate effects of UVA irradiation include depletion of 
intracellular glutathione (GSH) and alteration in gene expression. Tyrrell and Pidoux in 
1988, suggested that UVA radiation cytotoxicity is directly related to endogenous GSH 
levels. This was based on the observation that GSH depletion of human skin fibroblasts 
with buthionine-S,R-sulfoximine (BSO) could sensitise the cells to UVA radiation. Non­
toxic concentrations of BSO reduced cellular GSH by inhibiting a critical enzyme in 
GSH synthesis, y-glutamyl cysteine synthetase. These studies also provided evidence for 
the role of GSH in protecting cells against UVA damage possibly by acting as a H donor 
for glutathione peroxidase (GPx) and hence, reversing lipid peroxidation (see section 
1.4.4). In 1992, Lautier et al have further demonstrated that depletion of intracellular 
GSH could also enhance the accumulation of heme oxygenase (HO) mRNA in human
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skin fibroblasts after treatment with UVA radiation, supporting the hypothesis that 
cellular reducing equivalents are critical to UVA modulation of gene expression.
1.5 Heme oxygenase (HO)
Several studies have demonstrated that different forms of oxidative stress, including 
UVA radiation and H2O2, are capable of inducing gene expression in mammalian cells. 
Among these genes, HO has been shown to become highly activated under conditions of 
oxidative stress (Keyse and Tyrrell, 1989).
Heme oxygenase (HO) is a microsomal isozyme and one of its major functions is to 
catalyse the first and rate-limiting step in the oxidative degradation of heme to biliverdin, 
with the release of iron and carbon monoxide (CO) as shown in Figure 1.7. In turn, the 
biliverdin produced is converted to bilirubin in the cytosol. Bilirubin has been discovered 
as the most abundant endogenous antioxidant, since it accounts for the majority of the 
antioxidant activity of human serum (Gopinathan et al, 1994). In addition, HO is the 
major endogenous source of CO in the body. Carbon monoxide can act as a heme ligand 
and recent studies have demonstrated that it may have similar signalling functions to 
nitric oxide (NO) (Otterbein et al, 1999).
The active site of HO is located on the cytoplasmic site of the endoplasmic reticulum 
(ER) (Hino et al, 1979). In particular, there are three isoforms of mammalian HO: HO-1, 
an inducible enzyme that is most highly concentrated in tissues that are heavily involved 
in the catabolism of heme proteins; HO-2, a non-inducible isoform that is thought to be 
particularly involved in signalling pathways; and HO-3 which has low catalytic activity
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Figure 1.7: Diagrammatic representation o f heme degradation by HO.
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and an uncertain physiological role (Maines et al, 1986; McCourbey et al, 1997; Ortiz de 
Montellano, P.R., 2000).
Although, heme is the typical HO inducer several studies demonstrated that HO 
enzyme activity could also be stimulated by a variety of stressful stimuli including 
oxidants such as UVA and H2O2. Cellular susceptibility to oxidant-mediated killing is 
greatly increased by heme since it can readily enter the cell membrane and catalyse the 
oxidation of low-density lipoprotein (LDL) (Balia et al, 1991; Miller and Shaklai, 1994; 
Camejo et al, 1998). Deficiency of the heme catabolysing enzyme, HO-1, has also been 
shown to result to an abundance of the circulating heme. Recent studies (Jeney et al, 
2002) in human endothelial cells also indicated that when hemoglobin gets oxidised it 
can become directly cytotoxic through the generation of oxidised LDL due to the release 
of heme. As a result, both HO-1 and Ft are induced presumably as part of the intracellular 
antioxidant defence system.
Observations made in HO-1 deficient mouse and human have highlighted the 
important metabolic and cytoprotective role of this gene. Deletion of the mouse HO-1 
gene resulted in incapacity of mice to modulate body iron stores properly and were less 
resistant to hepatic injury by iron, indicating that HO-1 plays an important role in iron 
utilisation (Poss and Tonegawa, 1997).
HO-1 has also been shown to play a critical role in cardio-protection as it can 
partially rescue the heart from ischemia/reperfusion injury by functioning both as an 
intracellular antioxidant and inducer of its own expression under stressful conditions 
(Yoshiba et al, 2001). Furthermore, HO-1 is clearly a redox-regulated gene, since not 
only it is induced by several oxidants (Keyse and Tyrrell, 1989), but also because both
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basal and oxidant-induced levels of HO-1 accumulation are strongly increased by 
depleting cellular GSH (Lautier et al, 1992). UVA mediated activation of the HO-1 gene 
in human skin fibroblasts was efficiently blocked by ]C>2 quenchers such as sodium azide 
and was enhanced when cells were irradiated in the presence of deuterium oxide (D2O) 
(Basu-Modak and Tyrrell, 1993).
In addition to HO-1, the other two constitutive isoforms of heme oxygenase, HO-2 
(36 kDa) and HO-3 (33 kDa) have also been studied although their exact function has yet 
to be elucidated. So far, studies by Rotenberg and Maines (1991) and McCourbey et al 
(1997, 1993) have revealed that the amino acid sequence between HO-1 and HO-2 is 
around 40% similar and both isoforms display the same enzymatic activity and hence the 
molecular mechanism of the enzyme action should be analogous. Ishikawa et al (1995) 
that expressed the human HO-2 protein in a bacterial expression system, suggested that 
the HO-2 catalytic mechanism of heme degradation is very similar to HO-1. Finally, in an 
HO-2 gene-deletion mouse model, HO-1 induction increased oxidative damage during 
hyperoxia by mechanisms that appeared to involve a two-fold increase in lung GSH and 
accumulation of redox active iron (Dennery et al, 1998), suggesting an indirect role for 
HO-2 in induction of oxidative damage.
The function of the third iso form of heme oxygenase (HO-3) still remains unknown. 
The only proposed mechanism regarding its function is that since it contains a heme 
regulatory motif, it might be a heme sensing/binding protein (reviewed by McCourbey et 
al, 1997).
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1.6 Cellular defence mechanisms
Because of the involvement of ROS in damaging effects much attention has been 
drawn to the cellular antioxidant systems and their importance in prevention or removal 
of the damage. Cellular defence mechanisms include non-enzymatic and enzymatic 
systems, which sometimes act in synergy. A non-enzymatic defence molecule is GSH. Of 
the known enzymatic antioxidant systems, the best characterised are GPx, superoxide 
dismutases and catalase, which directly metabolise free radicals. Finally, the inducible 
protective pathways are also of essential contribution to cellular defence.
1.6.1 Non-enzvmatic antioxidant defence
Glutathione (GSH), a ubiquitous tripeptide, is present in most mammalian cells at 
high concentrations and is believed to play a crucial role in the protection of cells against 
oxidative damage (Meister and Anderson, 1983). GSH biosynthesis is controlled by 
multiple enzyme systems. The first step of GSH biosynthesis is catalysed by y-glutamyl 
cysteine synthetase (y-GCS), a heterodimer consisting of a 73 kDa heavy subunit (y- 
GCSh) and a 28 kDa light subunit. Although, the y-GCSh subunit contains the entire 
catalytic activity, its activity can be modulated by the association with the light subunit, 
also called the regulatory subunit (Meister, 1988 and O’Brian and Tew, 1996). GSH is a 
powerful radical scavenger and acts as the unique hydrogen donor for protective enzymes 
such as GPx and GSH transferase (GST), resulting in the formation of GSH disulphide 
(GSSG or oxidised glutathione) (Tyrrell, 1994). GSSG is reduced to GSH by glutathione 
reductase (GR) in the presence of NADPH as the hydrogen donor.
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Previous observations by Tyrrell and Pidoux (1986 and 1988) in cultured human skin 
fibroblasts and keratinocytes, have shown an increase in sensitisation of cells to the lethal 
effects of UVA by inhibiting GSH metabolism. GSH was depleted by treatment with 
buthionine S-R Sulfoximine (BSO), which reduces the cellular GSH levels via inhibition 
of the critical enzyme in GSH synthesis, y-GCS. Also, GSH has been shown, by Fischer- 
Neilsen et al (1992 and 1993), to protect Chinese Hamster Ovary (CHO) cells against 
UVA irradiation. Recent studies by Chang et al in 2002, also showed a close association 
between GSH and protection of T lymphocytes against oxidative damage. Significant 
increase in GSH levels in Jurkat T cells was found to decrease the formation of ROS and 
activated the induction of apoptosis.
In addition to GSH, other antioxidant vitamins, such as vitamins C and E, may play a 
protective role against UVA induced oxidative damage. Vitamin E comprises at least 
eight isomers of tocopherol and is a major lipophilic antioxidant. It acts during lipid 
peroxidation by donating labile hydrogen to terminate propagating LO* and LOO* groups 
and other radicals such as O2 and OH . Vitamin C is a hydrophilic antioxidant and reacts 
directly with a wide range of ROS (Haliwell and Gutteridge, 1999). It is able to quench 
]02 (Chou and Khan, 1983) and it can restore properties of oxidised vitamin E. Both 
vitamin E and vitamin C have complementary roles in preventing lipid peroxidation 
induced by oxidative stress, as reviewed by Tyrrell, 1994.
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1.6.2 Enzymatic defence-antioxidant enzymes
The major antioxidant enzymes include catalase which destroys H2O2, superoxide 
dismutase (SOD) which converts 0 *2” to H2O2 and GPx that metabolises H2O2 and reduces 
lipid peroxidation radicals such as LOOH.
Catalase is an enzyme that is located in the peroxisomes. Catalase destroys H2O2 by 
catalysing the direct decomposition of H2O2 to ground state oxygen and water. Also, 
there is evidence showing that catalase activity is strongly inhibited after UVA exposure, 
of cultured human fibroblasts and keratinocytes (Punnonen et al, 1991; Moysan et al, 
1993; Tirache et al, 1995; Shindo et al, 1997). However, comparing catalase activity to 
GSH, catalase is less important for the protection of cells against oxidative damage, since 
it has been shown that when cells are deficient in catalase, there is no decrease in cell 
survival after UVA radiation (Tyrrell and Pidoux, 1989; Peak et al, 1990).
SODs are located in the cytosol, mitochondria and plasma membranes, and catalyse 
the reduction of C ff to less reactive H2O2. The activity of SOD varies among the tissues 
and its activity is regulated through biosynthesis, which is sensitive to tissue oxygenation 
(Yu, 1994). Since SOD reduces Cff to H2O2, the increase in SOD activity has been shown 
to be accompanied with an increase in catalase and/or GPx to prevent H2O2 toxicity 
(Amstad et al, 1991 and Yohn et al, 1991).
GPx is a selenium dependent enzyme, located in the cytosol and mitochondrial 
matrix. GPx acts by coupling the reduction of H2O2 and lipid peroxides with the 
oxidation of GSH, forming water and alcohol, respectively.
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GPx
2GSH + H20 2  ► GSSG + 2H20
or 2GSH + LOOH G Px- »  GSSG + H20  + L0H
GPx according to studies by Lecia et al (1993) can also significantly decrease the 
level of UVA-induced oxidative membrane damage. Recently it has been shown that low 
doses of UVA radiation lead to an up-regulation of GPx activity, protecting cells against 
subsequent challenge of higher doses of UVA (Meewes et al, 2001).
1.6.3 Inducible cellular defence 
1.6.3a The protective role of ferritin
The catalytic role of iron in the generation of ROS anticipates the important role of Ft 
in modulating cellular sensitivity to oxidative stress. Early studies, by Balia and co- 
workers in 1992, revealed that heme induced Ft synthesis in endothelial cells and 
subsequently reduced their cytotoxic response to H20 2. During the following year, in 
tumour cell lines, it was demonstrated that sensitivity of these cells to oxidants was 
inversely correlated with Ft protein levels, since alteration in Ft levels with hemin could 
alter oxidant sensitivity (Cermak et al, 1993). In 1995, Cairo et al demonstrated that 
under conditions (in vivo) of oxidative stress, liver Ft can represent either a pro- or and 
anti-oxidant mode. Observations of the cooperative work between the cleavage by HO 
and Ft degradation to increase the intracellular LIP levels were also proposed. Indeed, 
expansion of LIP levels induced Ft at the transcriptional level and decreased IRP binding 
activity. There are also recent observations showing that increased Ft levels reduce the
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levels of LIP (Picard et al, 1998). These studies were also supported by data showing that 
reduction in Ft sensitised cells to oxidant cytotoxicity. In brief, when cells overexpressed 
Ft, both the oxidant toxicity in the cells was reduced as well as the importance of H-Ft 
ferroxidase activity (Epsztejn et al, 1999 and Cozzi et al, 2000). Other prooxidant 
conditions including treatment with H2O2 also suggested the cytoprotective role of Ft, 
whose role in sequestering LIP limited oxidative damage induced by H2O2 (Cairo et al, 
1995 and Cermak et al, 1993). Both transcriptional and post-transcriptional mechanisms 
have been implicated in Ft induction by oxidants. Transcriptional induction of H-Ft genes 
in rat livers and GSH reduction resulted in cellular defence against cytotoxicity of ROS 
formation (Cairo et al, 1995). Furthermore, studies by Lin and Girotti (1997) showed that 
hemin-stimulated cells had increased up to 3-times the levels of Ft molecule compared to 
nonstimulated controls. These findings supported the hypothesis that induced Ft, enriched 
in H-chain, sequesters redox active iron and thereby enhances resistance of cells to 
oxidants. Finally, studies on the contribution of IRP1 inactivation through oxidation of 
critical cysteine residues leading to Ft induction were very contradictory on the protective 
role of Ft against oxidative stress (Pantopoulos and Hentze, 1995 and 1998).
1.6.3b The role of heme oxygenase
The regulation of HO is an excellent model of a cellular pathway that has evolved to 
protect cells against oxidative stress. The inducible form of HO, the HO-1, has been 
shown to play a crucial role in protection of the cells against the toxic effects of different 
oxidising agents such as UVA and H2O2 (Keyse and Tyrrell, 1987 and 1989, Lautier et 
al, 1992 and Vile and Tyrrell 1993). Moreover, recent studies by Ferris et al (1999) also
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showed that absence of HO-1 leads to iron accumulation, whereas HO-1 overexpression 
decreases cellular iron levels. Protection of cells by HO-1 parallels a decrease in 
intracellular iron levels, and H O -l’s protection of cells following oxidative stress is 
mimicked by iron chelation.
Interestingly, it is now well recognized that the enhanced protective role of HO-1 is 
central to the development of an adaptive response that involves Ft. The overall effect of 
HO is to remove the pro-oxidant heme while generating the anti-oxidant, bilirubin, and 
another pro-oxidant, iron, that will be taken up by Ft. Vile et al in 1994 clearly 
demonstrated that when human skin fibroblasts were treated with HO-1 anti-sense 
oligonunleotides, the UVA-induced increase in Ft levels was prevented as well as the 
adaptive response that leads to protection against oxidative damage. An additional study 
by Rothfuss et al (2001) in human lymphocytes also demonstrated the functional 
involvement of HO-1 against the induction of oxidative DNA damage, but the exact 
mechanism remains to be elucidated.
1.7 Concluding remarks on the role of iron in oxidative stress
Pourzand et al (1999) have provided the first evidence that UVA radiation leads to an 
immediate increase in the “free” iron mainly as a result of degradation of Ft molecule. 
Indeed, the immediate decrease in IRP1 binding activity after UVA radiation coincided 
with a significant decrease in Ft levels. The lack of Ft would be expected to further 
exacerbate the damaging effects of LIP release in human cells. Pourzand et al (1999) also 
showed that Ft degradation that occurs immediately after UVA radiation originates from 
destabilisation of lysosomal membranes and the subsequent leakage of proteolytic
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enzymes from these organelles. This results in the release of “free” iron in the cells, 
which is potentially harmful (Figure 1.8).
Iron is also liberated from Ft as a consequence of normal turnover in lysosomes, 
where it is recycled for heme synthesis. According to Vaisman et al (1997) intracellular 
Ft donates iron for heme synthesis. Ferritin degradation caused by lysosomal damage is 
necessary for iron release and its transfer to heme. In addition to UVA-induced increase 
in LIP, Kvam et al (1999) have also demonstrated that UVA radiation induces the release 
of free heme within microsomal membranes of skin fibroblasts, resulting in the 
sensitisation of cells to a further exposure to UVA. Heme itself is not a source of the LIP, 
but it is a substrate for heme-catabolising enzyme, HO, which could release the heme 
iron.
Support for the concept that the induction of HO is an immediate response to break 
down heme has been provided by further studies with human skin fibroblasts. In 
particular, Noel and Tyrrell (1997) demonstrated that there is a refractory response to 
UVA activation of HO-1 expression that gradually develops to a maximum at 48h 
following the initial irradiation. This led to the conclusion that long-term activation of 
HO-1 expression can be damaging to the cell and therefore a mechanism for down- 
regulation is required.
Previous studies from this laboratory (Keyse and Tyrrell, 1989; Vile and Tyrrell, 
1993; Vile et al, 1994) have demonstrated that UVA radiation induces strong 
transcriptional activation of HO-1 gene in human primary skin fibrobasts, which 
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Figure 1.8: Diagrammatic representation o f the main steps involved in the UVA-mediated damage in 
human skin cells, as proposed by Pourzand et al (1999).
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In summary, cytoprotective effects o f HO may be due to several functions: first, 
because increased levels of heme enhance the prooxidant state of the cell, the degradation 
of heme by HO may be an adaptive mechanism in response to oxidative stress. Secondly, 
HO may exert its antioxidant function via the production of bilirubin, which is a very 
efficient scavenger of free radicals. And finally, HO-1 mediated induction of Ft has been 
accepted as an additional adaptive response of cells to oxidative stress as intracellular 
free iron is sequestered by Ft and the induction of Ft by oxidants appears to be coupled to 
induction of HO-1 (Fogg, et al, 1999).
In addition to UVA, H2O2 is another form of oxidizing agent. It is well known that 
when cells are exposed to external H2O2, the H2O2 rapidly diffuses inside the cell and 
oxidises Fe2+, thereby forming OH*. Once inside the cells H2O2 can degrade certain 
hemoproteins, including myoglobin, hemoglobin and cytochrome c, promoting the 
release of iron inside the cells. For example, a study by Stridh et al (1998) demonstrated 
that there is a cytochrome c release and caspase activation in H2O2 treated cells that result 
in apoptosis (see section 1.8). Following this observation, Antunes et al (2001) and Yu et 
al (2003) suggested that cytochrome c release is probably due to the enzymes activated 
by lysosomal rupture. These data showed that a low steady-state concentration of H2O2 
can cause lysososmal rupture, which after several hours leads to the induction of 
apoptosis. Their hypothesis was also supported by pre-treatment of cells with the iron 
chelator desferrioxamine (DFO), which inhibited both lysosomal rupture and apoptosis 
and correlated the involvement of intralysosomal iron as a major determinant of H2O2 
induced cell death.
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The reactivity of H2O2 with iron intimately connects oxidative stress and cellular iron 
metabolism. Studies from Pantopoulos and Hentze (1995) and Pantopoulos et al (1997), 
indicated that exposure of cells to H2O2 leads to reduced synthesis of Ft and stimulates 
TfR mRNA expression, which mediates iron uptake into the cells. Both responses were 
triggered via the induction of IRP1 binding activity following H2O2 treatment. The 
regulation of Ft and TfR expression by H2O2 via IRP1 provided a novel pathway in 
response to oxidative stress in mammalian cells. However, the data also suggested that 
IRP1 responds differently to oxidative stress when the oxidizing agent (H2O2) is applied 
exogenously as compared to endogenous generation of H2O2 i.e exogenous H2O2 
treatment resulted in rapid activation of IRP1, while elevation of intracellular H2O2 levels 
were not sufficient for the induction of IRP1.
In general these findings demonstrate that the effects of H2O2 on cellular iron 
metabolism are complex and involve both IRP1-dependent and independent mechanisms 
that need to be investigated further.
Recent work from our laboratory have also showed that exogenous H2O2 promotes 
the release of “free” iron in the cytosol of human skin fibroblasts, although the exact 
pathway has not yet been identified (unpublished data).
In vivo work on the role of Ft ferroxidase activity (Cozzi, et al, 2000) demonstrated 
that the overexpression of H-Ft induces both iron deprivation and increased resistance to 
oxidative damage by H2O2.
Overall, oxidative stress, either in the form of UVA or in the form of H2O2, affects 
iron metabolism via an increase in LIP levels, a decrease in Ft levels and the release of 
free heme within microsomal membranes.
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Finally, several studies have shown that UVA can cause damage to various cellular 
compartments and that endogenous antioxidant mechanisms influence most of the action 
of UVA radiation.
1.8 Consequences of oxidative stress: cell death
Cell’s exposure to oxidative stress can lead to cell death. Cell death can occur 
essentially by two mechanisms, necrosis and apoptosis. Apoptosis and necrosis are two 
forms of cell death with clearly distinguishing morphological and biochemical features 
(Wyllie et al, 1980). Necrosis is the pathological process, which occurs when cells are 
exposed to a serious of physical or chemical insult whereas apoptosis or programmed cell 
death is the physiological process responsible for the elimination of superfluous, aged or 
damaged cells. Although apoptosis is necessary for both health and disease, necrosis is 
always the outcome of severe and acute injury.
Apoptosis and necrosis have long been considered as two distinct mechanisms of cell 
death, each with different biochemical and morphological characteristics (see Table 1.1 
and Wyllie et al, 1980; Majno and Jorris, 1995). Indeed, apoptotic cells are defined by 
fragmented nuclei with condensed chromatin, fragmented or condensed cytoplasm and 
formation of apoptotic bodies, whereas necrotic cells are characterised by electron-lucent 
cytoplasm, mitochondrial swelling and loss of plasma integrity without severe nuclear 
damage.
However, it is now widely accepted that apoptosis may also be triggered in response 
to toxic stimuli and oxidative stress (Dypbukt et al, 1994) or in association with necrosis 
(Staunton and Gaffney, 1998). In particular, it has been shown that it is the magnitude of
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Morphological 1. Plasma membrane near-to-intact 1. Loss of membrane integrity
until late 2. Early swelling of cytoplasm
2. Shrinking of cytoplasm and and mitochondria
nuclear condensation 3. Leakage of cell, complete
3. Fragmentation of cell into lysis
smaller bodies and formation of 4. Disintegration of organelles
apoptotic bodies
4. Mitochondrial leakage
Biochemical 1. Energy (ATP)-dependent 1. No energy requirement
process process
2. Release of various factors into 2. Loss of regulation of ion
cytoplasm by mitochondria homeostasis
3. Activation of caspase cascade 3. DNA fragmentation
4. Alterations in membrane
asymmetry by translocation of
phosphatidylserine from the
cytoplasm to the extracellular
Table 1.1: A comparison o f different features o f apoptosis versus necrosis.
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the initial insult, rather than the type of the stimulus that plays a critical role in the 
decision of the cell to undergo either apoptosis or necrosis, proposing that apoptosis and 
necrosis may not necessarily be two independent pathways but may share common 
events, at least in early phases of cell death process and in the signal transducing pathway 
(Bonfoco et al, 1995; Shimizu et al, 1996; Hampton and Orrenius, 1997).
On the basis of these findings, it has now been recognised that the downstream 
controller capable of directing the cells toward either type of cell death is intracellular 
ATP (Ellerby et al, 1997) as well as caspase activation. In particular maintenance of high 
ATP favours apoptosis over necrosis whereas ATP depletion and inhibition of caspase 
activation transforms apoptosis into necrosis.
The first step in the induction of cellular death by various stimuli is the increase in 
mitochondrial membrane permeability. A dynamic megachannel multiprotein complex 
formed in the contact site between the inner and the outer mitochondrial membranes is 
the mitochondrial permeability transition pore (PTP). The PTP complex can function as a 
sensor of oxidative stress since PTP opening can be triggered by several effectors such as 
ROS, pH changes, reduced concentrations of adenine nucleotides (ATP, ADP) and 
collapse of mitochonrial membrane potential (A'Pm). As a consequence of mitochondrial 
dysfunction, soluble proteins contained in the mitochondrial intermembrane space 
(cytochrome c, apoptosis-inducing factor) are released through the outer membrane into 
the cytosol and activate a class of proteases, the caspases (cysteine aspartate-specific 
proteases) (reviewed by Kroemer et al, 1998).
In brief, once released cytochrome c initiates formation of the apoptosome, which is 
a complex of Apaf-1 (apoptotic protease activating factor-1) and caspase 9. Indeed
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cytochrome c acts in concert with ATP to induce conformational change in Apaf-1 that 
allows it to bind to pro-caspase 9 and form the apoptosome. The apoptosome will act as 
an initiator of the caspases which will lead to the cleavage of cellular proteins and 
apoptosis. Activation of caspases is regulated directly or indirectly by members of the 
Bcl-2 family that appear to regulate the release of cytochrome c from mitochondria and 
the subsequent activation of the apoptosome.
The Bcl-2 family of proteins possesses both pro-apoptotic (Bax, Bad, Bid, Bak, Bcl- 
Xs, Bik, Bim, Hrk) and anti-apoptotic (Bcl-2, Bc1-X l, Bcl-W, Mcl-1, A l) molecules. It 
is the ratio o f anti- to pro- apoptotic molecules (i.e. Bcl-2/Bax) that determines the 
response to a death signal. Overexpression of Bcl-2 in cells has been reported to block 
cell death, the reduction of A'Fm and the release of cytochrome c from mitochondria 
whereas Bax induces these changes. Reed and co-workers (1998) have suggested that 
Bax plays a crucial role in the opening of the PTP and dissipation of A'Fm via the 
participation of either in the formation or regulation of the megachannel, whereas Bcl-2 
blocks its process.
Bcl-2 is localised in the mitochondrial membrane and therefore accumulation in its 
function can be associated with oxidative membrane damage. As already mentioned in 
previous sections, UVA is a strong membrane damaging agent and induces peroxidation 
o f membrane lipids in human skin cells. Pourzand et al (1997) demonstrated that 
overexpression of Bcl-2 inhibits UVA-mediated immediate apoptosis, supporting the 
notion that Bcl-2 apart from its antiapoptotic function, possesses antioxidant properties. 
They also showed that expression of Bcl-2 dramatically decreases the level of HO-1 
induction following UVA radiation.
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The same spectrum of protection of Bcl-2 against oxidative damage has also been 
supported by the overexpression of B c1-Xl in astrocytes. In this study, they demonstrated 
that overexpression of B c1-Xl protects astrocytes from oxidative damage and is 
associated with higher GSH, Ft and iron levels (Xu et al, 1999).
Singlet oxygen and superoxide anion are two generators of UVA that have been 
shown to activate the PTP, which in turn triggers immediate apoptosis (Godar, 1999). 
The author proposed a model in which opening of the PTP sites by 102 and superoxide 
anion provokes the release of AIF and cytochrome c release from mitochondria. In 
addition, a study in human HL-60 leukemic cells showed that an early decrease in A'Fm 
following UVA radiation, activated caspase 3 and subsequently apoptosis (Tada-OiKawa 
et al, 1998).
Although most current studies on oxidative stress-induced apoptosis focus on 
caspases, mitochondrial energy changes and plasma membrane-bound death receptors, 
evidence has been brought forward for the role of lysosomes in the initiating phase of 
apoptosis (Brunk et al, 1997; Brunk and Svensson, 1999). Recent studies by Zhao et al 
(2003) have demonstrated that exposure of human skin fibroblasts to oxidant stress 
caused early release of lysosomal enzymes promoting the release of ctytochrome c due to 
enhanced mitochondrial oxidant production and initiation of the apoptosis.
Moreover, a study by Antunes et al (2001) demonstrated that apoptosis as a 
consequence of lysosomal rupture is also induced by a low steady-state concentration of 
H2O2. These data showed that a short exposure (15 min) to H2O2 caused the immediate 
lysosomal damage and later apoptosis and this could be inhibited by the use of 
desferioxamine (DFO), an iron chelator which is known to be taken up by endocytosis
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and become localised in the lysosomes. These findings also proposed a link between intr- 
lysosmal iron-catalysed oxidative damage and induction of apoptosis.
However, it is important to mention that recent study presented by Brunk in the 
European Iron Meeting (Brunk, T., Yu, Z., Persson, L. and Eaton, J.W., (2003), 
Lysosomes, Iron and Oxidative stress, European Iron Club, Vienna) showed that when 
Jurkat T cells were exposed to higher doses o f H2O2 and for a prolonged time, no 
induction of apoptosis could be detected. In support of this study data from our laboratory 
have also clearly demonstrated that UVA and H2O2 treatment of human skin fibroblasts 
causes a dose dependent induction of necrosis rather than apoptosis (unpublished data, 
this laboratory). Study of this thesis will also focus on the identification of the mode of 
cell death induced by two different forms of oxidative stress, UVA and H2O2 (see 
chapters 3 and 4).
1.9 Multidrug resistance (MDR)
In cancer treatment, one of the major problems to be overcome is the resistance of 
tumour cells to anticancer drugs. An intensively studied type of cellular drug resistance is 
the multidrug resistance (MDR) phenotype. Multidrug resistance is the phenomenon 
where cells exposed to one drug often develop resistance not only to that drug, but also to 
other drugs to which they have never been exposed.
In vitro studies have shown that MDR is accompanied by reduced intracellular drug 
accumulation due to increased efflux via energy dependent trans-membrane drug 
transport proteins (Endicott and Ling, 1989). These trans-membrane transport proteins
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belong to the ABC transporter superfamily because each member contains a highly 
conserved ATP-binding cassette (ABC).
Over 50 ABC transporters have been described, and although most o f the members 
have been described in prokaryotes, an increasing number are being discovered in 
eukaryotes. The first of these to be identified were discovered because of their ability to 
pump hydrophobic drugs out of eukaryotic cells. Members of the ABC family include the 
P-glycoprotein (PgP), the multidrug resistance protein (MRP) and a newly described 
mitoxantrone resistance protein (MXR or ABCG2). Another protein is the lung resistance 
protein (LRP), which although is not an ABC transporter, it is frequently involved in 
discussions of drug resistance. These act as ATP-dependent pumps, pumping anti-cancer 
drugs out of the cells and thus decreasing their intracellular accumulation and therefore 
their effectiveness to treat cancer cells.
1.9.1 The P-glycoprotein (PgP)
The multidrug transporter, PgP is a transmembrane 170 kDa glycoprotein, encoded 
by the mdrl gene and overexpressed in various drug-resistant tumour cells. PgP is 
comprised of two similar halves (43% sequence homology), each containing 6 
transmembrane domains, three glycosylation sites on the first extracytoplasmic domain 
and an ATP-binding consensus motif (Chen et al, 1986). PgP functions as an energy 
dependent efflux pump responsible for the removal of lipophillic and natural compounds 
out of tumour cells (Endicott and Ling, 1989).
P-glycoprotein was initially isolated due its role in MDR to cancer 
chemotherapeutics. In recent work, however, it is evident that this transporter is also
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involved in the pharmacokinetics of many drugs. P-glycoprotein is expressed in many 
cells and is often associated with drug absorption and disposition.
Several mechanisms have been suggested to explain the PgP transport function. The 
model of Higgins and Gottesman (1992) proposed that PgP encounters xenobiotics in the 
inner leaflet of the plasma membrane and flips the agents to the outer leaflet, where they 
diffuse into extracellular region (Figure 1.9) and therefore promoting the translocation of 
a wide variety of short-chain lipid molecules (Helvoort et al, 1996). P-glycoprotein has 
also been postulated to increase intracellular pH via depolarising plasma membrane 
electric potential of the cell by acting as a proton pump, or a chloride channel, thus 
reducing intracellular accumulation of weak bases or reducing pH-dependent binding of 
agents to their intracellular targets (Roepe et al, 1993). Hence, PgP appears to be itself 
capable of direct substrate transport.
P-glycoprotein expression has been studied in many tumours, since its overexpression 
in tumour cells results in reduced intracellular accumulation of anticancer drugs including 
arthracyclines and vinca alkaloids and enhanced drug efflux and thus contributes to 
MDR. Treatment of an MDR human hepatoma HepG2 cell line with antisense RNA 
against mdrl gene resulted in inhibition of PgP expression and reduction in drug 
resistance (Chan et al, 2000).
Much interest is focused on identifying chemical agents that can antagonise drug 
transport by PgP. To this regard, Mardeuf-Gueye et al (2000) have demonstrated a new 
compound (PAK-104P) that can inhibit the drug efflux by two mechanisms: a first 
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Figure 1.9: Diagrammatic representation o f the proposed model by Higgins and Gottesman (1992) on the 
function o f the PgP pump. (Adapted from Krishna and Mayer, 2000)
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on GSH. A second mechanism involving a high affinity site for PAK-104P, which efflux 
depends on the presence of GSH.
Wigler and Patterson (1993) have demonstrated that inhibitors of PgP can resensitise 
MDR cells and hence PgP inhibitors have been used as modulators of MDR. The PgP 
reversing agent, verapamil, can modulate resistance in MRP overexpressing cells (Lautier 
et al, 1996). In addition, studies of a PgP negative multidrug resistant cell line led to the 
identification of another MRP.
The function of PgP as a transporter of known substrates is utilised in functional 
assays of PgP detection. The earliest assays included radiolabelling of anticancer drugs 
such as vincristine and doxorubicin but lately new methods were developed based on 
fluorochromes as PgP substrates (i.e. rhodamine 123 and 3,3'-diethyloxacarbocyanine 
iodide DiOC2(3)) using flow cytometry. However, diversities in fluorescence can not 
always be linked to different levels of PgP expression, since other transport mechanisms 
may contribute to the drug or dye efflux. Therefore, combined incubation in the presence 
or absence of selective inhibitors of PgP function provides increasing specificity of the 
functional Pgp assays (Feller et al, 1995).
There are various agents that antagonise MDR by increasing the drug accumulation in 
MDR cells, whereas they show little or no effect on drug-sensitive cells. Most of these 
reversing agents, such as verapamil and cyclosporine are substrates for PgP mediated 
transport and competitively inhibit PgP transport of anti-tumour drugs.
P-glycoprotein is also present in various normal tissues such as gastrointestinal tract, 
liver, kidney as well as brain. P-glycoprotetin activity in normal tissues suggests an 
important role in transepithelial transport. Recent studies have shown that PgP is also
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expressed in keratinocytes and might play a role in regulating the level of environmental 
toxins and differentiation factors (Sleeman et al, 2000).
1.9.2 The multidrug resistance protein (MRP)
The MRP is a 190 kDa transmembranous glycoprotein which was identified by Cole 
et al (1992). MRP has been mainly identified in drug resistance o f haematological 
malignancies, lung cancers, acute lymphoblastic leukaemia relapses and chronic myeloid 
leukaemia, but its contribution to chemoresistance of other tumours such as melanoma 
are under investigation.
Although MRP is similar to PgP in terms of substrate specificity, only 15% amino 
acid homology exists between the two proteins. Functionally, MRP differs from PgP in 
being capable of transporting organic anion drug conjugates as well as intact anticancer 
drugs (Cole et al, 1992; Loe et al, 1996). Unlike PgP, it has not been possible to 
demonstrate that MRP binds and actively transports unmodified forms of the drugs to 
which it confers resistance. The ability of MRP to function as an ATP-dependent 
membrane transport of anionic conjugates of endogenous and exogenous substance from 
cells into the extracellular space at a sufficient rate has been characterised by many cell 
types (Figure 1.10) (Konig et al, 1999). Specifically, the transport and detoxification of 
substances (e.g drugs, carcinogens) entering the cells involve firstly the oxidation of the 
substance. Subsequently, biotransformation processes catalysed by GST conjugate the 
substance with GSH, resulting in the export of the conjugated substance by the MRP 











Figure 1.1 O’. Diagrammatic representation o f the MRP export mechanism. (Adapted from Konig et al, 1999)
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Contribution of the MRP to the chemoresistance of melanoma cells is under 
investigation. In a recent study, Berger and coworkers (1997) have shown that in 50 cases 
of melanomas, resistance to daunomycin and doxorubocin, was entirely correlated with 
MRP gene expression.
MRP is also expressed in normal human tissues such as muscle, lung, spleen, bladder, 
adrenal gland and gall bladder (Zaman et al, 1993). Recently several isoforms of MRP 
have been identified, namely MRP1, MRP2 and MRP3-6. MRP1 and MRP2 function as 
organic anion transporters (Borst et al, 1997). MRP1 plays also a physiological role in 
the normal ATP-dependent membrane transport of GSH conjugates.
1.9.3 The mitoxantrone (MXR or ABCG2)
The MXR has been recently identified by Miyake et al (1999) in a human colon 
cancer subline, S I-M l-80. It is a 655-amino-acid protein with six transmembrane 
domains and is encoded by the mitoxatrone resistance-associated gene mxr (Litman et al, 
2000). Research on the examination of the phenotype of two mxr-overexpressing cell 
lines demonstrated a parallel phenotype with similar patterns of cross-resistance, 
matching drug distribution profiles and energy-dependent mitoxantrone efflux. This 
newly identified mechanism of resistance extends to numerous other anticancer agents 
and appears to be as potent as PgP in conferring MDR (Litman et al, 2000).
The MXR is an ABC half-transporter that is thought to dimerize to function and is 
expressed in high levels in the placenta. It has been shown to confer resistance to 
mitoxantrone and anthracyclines (Robey et al, 2001). In addition, MXR was also shown 
to play a role in the resistance of human breast cancer cells to flavopiridol, an inhibitor of
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the MRP-mediated transport (Robey et al, 2001). Thus, MXR provides a potent new 
mechanism for MDR.
Finally, a recent study by Diah et al (2001) provided new evidence on the role of 
MRP in the emergence of MXR cross-resistance in breast cancer cell lines. They 
demonstrated that there was an increased MXR efflux in MRP1 overexpressing breast 
cancer cell lines probably due to a novel transport mechanism of glutathione-independent 
MRP1 substrates, since they found no evidence for involvement of GSH or other 
conjugates on MXR transport.
In conclusion, it is important to point out that the fact that multiple transporters can 
affect individual anticancer agents has significant implications for studies attempting 
reversal of drug resistance. As a consequence, there is overlapping substrate specificity of 
MDR, MRP and MXR as illustrated in Figure 1.11. Mitoxantrone and daunorubicin were 
accumulated in all M D R -, MXR- and MRP- expressing cells whereas drug accumulation 
profiles with known PgP substrates (bisantrene, topotecan, rhodamine 123 and prazosin) 
were expressed in MDR- and MXR- overexpressing cells (Litman et al, 2000). In 
contrast, the PgP substrate, vinblastin appeared not to be a good transport substrate for 
the MXR sublines whereas paclitaxel, non-fluorescent calcein-AM ester and colchicine 
were transported only from the MDR-overexpressing cell line (Litman et al, 2000 and 
Versantvoort et al, 1995). Consistent with this, a fluorescent analogue of the MDR 
reversing agent verapamil was clearly transported only from the MDR-overexpressing 
cell line (Litman et al, 2000). In contrast, the UV-excitable compound 
monochlorobimane was excluded only in the MRP-overexpressing cells, suggesting a
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role of MRP as a glutathione S-conjugate pump, since monochlorobimane becomes 
fluorescent when bound to GSH (section 1.10) (Millis et al, 1997 and van Luyn et al, 
1998). In addition, transport of calcein was only apparent in MRP-overexpressing cells 
(Litman et al, 2000). These observations highlight further both the complexity of MDR 
and the need for development of new and more specific inhibitors of clinical drug 
resistance.
1.9.4 The lung resistant protein (TRP)
Lung resistant protein (LRP) is the 110 kDa human major vault transporter protein 
originally isolated from PgP-negative multidrug resistant cells. LRP is found in the 
cytoplasm and on the nuclear membrane and appears to function as a bi-directional 
nucleo-cytoplasmic transporter of molecules and particles. LRP has been shown to be 
overexpressed in a variety of cancer cells and is often co-expressed with MRP gene in 
highly multidrug resistant cells (Izquierdo et al, 1996; Ikeda et al, 1998).
The LRP has been identified to be overexpressed in ovarian cancer, acute myeloid 
leukaemia (AML) and multiple myeloma. Finally, LRP is widely expressed in normal 
human tissue, including peripheral blood and bone marrow.
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Figure 1.11: Diagrammatic representation o f the substrate specificity o f the ABC-transporters, 
MDR, MRP and MXR in cell lines overexpressing MDR, MRP and MXR, respectively (Adapted 
by Litman et al, 2000)
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1.10 Evidence associating multidrug resistance and oxidative stress
The direct link between the MDR cells and resistance to oxidative agents is still 
controversial. Even so, it was primarily the work by Epsztejn et al (1999) that inspired us 
to study further the connection between MDR and oxidative stress. According to this 
study overexpression of H-Ft subunit in murine erythroid leukaemia cell line reduced the 
response of cells to oxidative stress by downregulating the level of the LIP in the cells 
and inducing MDR properties. In particular, the transient overexpression of H-Ft 
promoted a commensurate ability of cells to resist drug toxicity following oxidative 
challenges with H2O2. MDR properties of the H-Ft overexpressing cells involved 
increased levels of mdrl mRNA and protein (PgP) as well as drug transport and drug 
toxicity.
There are also studies indicating that hyperferritinaemic patients suffering from eye 
cataract overexpress the L-Ft subunit and develop MDR properties within the epithelial 
cells of the eye (Dunia et al, 1996).
Recently, it has been suggested that an elevation of intracellular ROS is downregulating 
PgP expression via activation of receptor tyrosine kinase signalling pathways 
(Wartenberg et al, 2001). Downregulation of PgP was also observed with low 
concentrations of H2O2 and epidermal growth factor (EGF), indicating that ROS may 
regulate PgP expression.
Free radicals can also be involved in the cytotoxic effects of anticancer agents. This 
hypothesis was investigated by Mazzanti et al (1996), whose work was based on the 
study of the link between MDR phenotype and free-radical stimulated lipid peroxidation.
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The authors demonstrated that the induction of the MDR phenotype in NIH 3T3 
fibroblasts increases the susceptibility of cells to both irradiation and iron stimulated lipid 
peroxidation.
Anthracyclines such as doxorubicin have also shown to cause cytotoxicity by 
generating ROS, so it is possible that resistance to doxorubicin could be associated with 
increased intracellular enzyme capacity to convert ROS into active metabolites. In a 
study by Kim et al (2001), a doxorubicin-resistant AML subline that overexpressed MRP, 
but not PgP, although was found to be resistant to other drugs such as daunorubicin and 
vincristine, showed sensitivity to H2O2. This data suggested that decreased catalase 
activity could be attributed to MRP overexpression, which could pump out substances.
It is well established that the use of doxorubicin as an anticancer drug is limited 
because it shows severe cardiotoxicity. The relationship between iron metabolism and 
doxorubicin cardiotoxicity has been studied with cardiac biopsies and cardiomyocytes 
(Minotti et al, 1998 and 2001). Minotti et al (2001) demonstrated that doxorubicin 
irreversibly inactivates IRP-1 and IRP-2 in cardiomyocytes.
Moreover, in relation to UV studies, Trindale et.al (1999) have observed that 
leukaemia cells exhibiting MDR phenotype and overexpressing PgP, were resistant to 
UVA but not UVB or UVC, presumably as a result of higher catalase activity.
MDR has been shown to be associated with increased cellular levels of GSH and/or 
GST. It has been reported that elevated GSH levels in y-GCSh transfected cells down- 
regulate MRP1 and y-GCSh expression, indicating that these two genes may be co- 
ordinately regulated (Yamane et al, 1998). In addition, a study by Renes et al (2000)
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indicated that MRP1 protects cells against the toxicity of lipid peroxidation products, 
specially the a ,(3-unsaturated aldehyde 4-hydroxynonenal (4HNE). GSH has a major role 
in the metabolism of 4HNE, since it can react with 4HNE using GST as a catalyst 
(Figure 1.12). Sometimes metabolites during GSH conjugation (GS-4HNE) become 
toxic by inhibiting GST activity. Such a conjugated product will then be transported 
across cell membranes via MRP1 efflux pump, leading to decreased intracellular 
concentration of toxins. Taken together, it appears that GS-4HNE is a new substrate for 
MRP1 and that MRP1, together with GSH, has a role in the defence mechanism against 
oxidative stress (see Renes et al, 2000).
Furthermore, a number of cell types have been shown to release GSSG via an MRP- 
mediated export mechanism. GSSG has been shown to be a substrate for MRP, 
suggesting that MRP by exporting GSSG compensates oxidative stress when GSSG 
becomes rate-limiting (Keppler, 1999). Also, Hirrlinger et al (2001) showed that H2O2- 
induced oxidative stress resulted in the production of GSSG and that its release was 
mediated by MRP.
It is well known that chemotherapeutic drugs such as doxorubicin, cisplastin and 
etoposide, cause apoptotic changes in the cell. It was initially a range of clinical studies 
that suggested that the expression of MDR genes involved in apoptosis affects 
chemosensitivity. Recent studies by Boland and co-workers (1997) showed that 
daunorubicin activates NFkB and induces kB-dependent gene expression in HL-60 and in 
Jurkat T lymphoma cells in association with the generation of ROS as a result of 
endogenous cellular processes that lead to apoptosis.
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Figure 1.12: Diagrammatic representation of the interrelation between MRP and GSH. Note that 4HNE is given as an example for this 
export mechanism of MRP and GSH.
Furthermore, studies by Matarrese et al (2001) have also indicated that expression of 
PgP could sensitise lymphoblastoid CEM cells to mitochondria-mediated apoptosis. In 
particular, they demonstrated that Pgp function is associated with a sort of sensitisation to 
mitochondrially bound apoptotic stimuli (i.e. tumour Necrosis Factor (TNF-a)) and 
proposed that this mechanism might be associated with specific modification of the 
membrane potential (i.e. A'F).
Although several studies have suggested that overexpression of the Apaf-1, required 
for mitochondria-dependent apoptosis, increases sensitivity to apoptosis induced by 
chemotherapeutic drugs, the first direct evidence was provided by Jia et al (2001) in 
human leukemic cells. They reported that constitutive variations in the levels of Apaf-1 
protein in human leukemic cells could determine sensitivity to apoptosis downstream of 
mitochondrial involvement. Using UV light as a stimulus to pass through the 
mitochondrial barrier, they demonstrated that radiation treatment resulted in the release of 
cytochrome c from mitochondria in all tumour cells and that the differential susceptibility 
to cytochrome c dependent apoptosis was associated with the Apaf-1 protein level in 
these cells.
Besides these observations, further understanding of the physiological role of each of 
the MDR transporters is critical for determining their role and evaluating the 
consequences of alterations in their activity under conditions of oxidative stress.
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1.11 Aim and objectives
Several recent studies (see section 1.10) have revealed that cells exhibiting MDR are 
also resistant to oxidizing agents including solar ultraviolet A radiation. However, the 
mechanisms underlying the appearance of such resistance are currently unknown. The 
objective of this project is to examine the functional link between MDR-associated 
proteins and resistance of cells to oxidizing agents such as H2O2 and UVA. To this regard 
we used a model of two human Jurkat T cell lines, one with non-resistance (parental) and 
one resistant to H2O2. Our primary goal was to characterise these cell lines in terms of 
susceptibility to oxidizing agents (i.e H2O2 and UVA) and investigate whether there is a 
correlation between LIP release and the susceptibility of cells to both oxidizing agents. 
Consequently our aim was to provide preliminary observations on correlation between 
the increased susceptibility of cells to oxidising agents and the level of expression of key 
MDR-gene products. Such studies are crucial for understanding of the mechanism of 
MDR and should provide evidence towards understanding of MDR expression and 





All the reagents were from Sigma-Aldrich Chemical Co. (Poole, UK) unless 
otherwise specified. All the cell culture materials were obtained from Life Sciences 
Technologies (Paisley, UK), except the foetal calf serum (FCS), which was obtained 
from PAA (Austria). Dulbeco’s Minimum Essential medium (DMEM) and Trizol were 
supplied by Gibco BRL Invitrogen Corporation (Life Technologies, UK). Calcein (CA), 
its acetoxymethyl ester (CA-AM) and the fluorescent dye, 3,3’-diethyloxacarbocyanine 
iodide (DiOC2(3)) were obtained from Molecular Probes (Leiden, Netherlands). 
Salicyladehyde isonicotinoyl hydrazone (SIH) was kindly provided by Prof. Ponka (Lady 
Davis Institute, Canada). Desferrioxamine mesylate (DFO) was from Novartis (Basel, 
Switzerland). Protease inhibitors and Annexin V were from Roche (Mannheim, 
Germany). HO-1 and HO-2 anti-human polyclonal antibodies were from Santa-Cruz 
Biotechnology. HO-1 monoclonal antibody was supplied from Stressgen Biotechnology, 
UK. Protein G-Sepharose and actin anti-mouse Ig, horseradish peroxidase (HRP), were 
from Amersham Pharmacia Biotech. ApoGlow Kit was supplied by Lumitech (UK).
2.2 Mammalian Cell Culture
The human Jurkat T cell lines (J16 and HJ16) were kindly provided by Dr. Nick Hall 
(Pharmacy and Pharmacology, Bath University, UK).
J16: The parental human Jurkat T cell line (stated as parental cells).
HJ16: The H2O2 resistant Jurkat T cell line derived from the parental J16 following 
gradual adaptation to 3mM H2O2 (stated as H2O2 resistant cells).
J16 and HJ16 cells were cultured routinely and incubated in a humidified atmosphere 
at 37°C with 5% CO2. Both cell lines were grown in RPMI-1640 medium, supplemented 
with 10% v/v FCS, 2 mM L-Glutamine, 50 IU/ml of each penicillin/streptomycin (P/S).
2.3 Treatments
2.3.1 UVA irradiation
The broad spectrum 4kW lamp (Sellas, Germany) emits primarily UVA irradiation 
(significant emission in the range of 350-400 nm) and some near-visible radiation longer 
than 400 nm. The spectrum of the lamp is shown below in Figure 2.1:
Figure 2.1: Spectrum of the Sellas 4kW UVA lamp.
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The UVA doses were measured using an IL1700 radiometer (International Light, 
Newbury, MA). Irradiation was carried out in an air-conditioned room at 18°C in order to 
maintain the temperature of the cells to approximately 25°C throughout the irradiation 
procedure.
^  I
Prior to irradiation, cells were washed with PBS and then PBS, containing 5ppm Ca
9+and Mg , was added to the cells in 6-cm plates. This was followed by irradiation of cells 
at 100, 250 and 500 kJ/m . Following the irradiation, the cells were resuspended in 
conditioned medium (the retained medium in which cells had been grown).
2.3.2 Hydrogen peroxide (FLCM treatment 
Stock solution: 176 mM in PBS.
H2O2 treatment was carried-out in serum free media (SFM) in order to avoid any 
interference of catalase from the serum. The cells were incubated with H2O2 in SFM at 
the final concentrations of 0.05, 0.1, 0.5, 1 and 3 mM for 30 min at 37°C.
2.3.3 Hemin and DFO treatments
Stock solutions: 20 mM hemin in dimethyl sulfoxide (DMSO)
150 mM DFO in H20
Prior to UVA and H2O2 treatments, cells were treated with hemin (20 jjM) or DFO 
(IOOjliM) for either 2 or 18h at 37°C.
2.3.4 Anti-cancer drug treatments
J16 cells were treated with a range of doses of anti-cancer drugs in SFM.
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Stock solutions: 1 mM of vinblastin, doxorubicin, mitoxatrone and verapamil in DMSO. 
Dose range of vinblastin: 20, 50 and 70 nM 
Dose range of doxorubicin: 5, 10, 20 and 50 pM 
Dose range of mitoxatrone: 20, 40, 80 and 100 pM
2.4 Flow Cytometry
Quantification of apoptosis, by Annexin V- Fluoroscan isothiocyanate (FITC) 
staining, and necrosis, by Propidium Iodide (PI) uptake, were evaluated by flow 
cytometry. Annexin V is a phospholipid-binding protein with a high affinity to 
phosphatidylserine (PS), which during apoptosis translocates to the outer surface of 
apoptotic cells. Detection of cell surface PS with Annexin V serves as a marker for 
apoptotic cells. However, necrotic cells are taken up by simultaneous staining with both 
Annexin V and PI. Therefore, Annexin V and PI double-staining can differentiate 
between necrotic and apoptotic cells.
After the different incubation periods, cells were incubated with incubation buffer (10 
mM Hepes/NaOH, pH 7.4, 5 M NaCl, 100 mM CaCl2) containing Annexin V (20 pl/ml) 
and PI (20 pl/ml) for 15 min. Double stained cells were considered necrotic whereas 
Annexin V positive, PI negative cells were apoptotic. A minimum of 10,000 cells were 
analysed per sample on a FACSvantage (Becton Dickinson, Erembodegen, Belgium). 
The following settings were used for all the analysed cell lines: FL1 (530 ±15  nm) in log 
data collection and FL3 in log data collection. The data was analysed using two- 
dimensional dot plots of FL3 versus FL1 fluorescent profiles. Data analysis was
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performed with CellQuest software (Becton-Dickinson, Erembodegem, Belgium) and a 
dual parameter of FL1 (Annexin V) and FL3 (PI) was used.
2.5 MTT assay
MTT [3-(4,5-dimethylthiazol-2-yl0-2,5-diphenyl tetrazolium bromide] assay was 
used in order to quantify the viability of the cells as well as cytotoxicity after treatments 
(Doyle and Griffiths, 1998). The principle of this assay is based on the capacity of 
intracellular dehydrogenase enzymes in living cells to convert the yellow-soluble 
substrate (MTT) in a dark blue formazan product that is water-insoluble. The amount of 
formazan produced is directly proportional to the cell number. Since a colorimetric assay, 
the analysis of results is performed using a micro-ELISA plate reader.
The procedure involves preparation of fresh MTT stock solution in serum free media 
(lm l of 5 mg/ml MTT diluted in 10 ml serum free media). After different post-incubation 
periods, cells were first diluted with MTT in SFM and then 200 j l l I  of each sample was 
added in triplicates, in a 96-well microplate. Plate was incubated for 3h at 37°C. After 
incubation, MTT solution was aspirated and 100 fxl of DMSO was added in each well. 
The plate was read in a 96-well microplate reader (Dynatech MR5000) at 550 nm.
2.6 Adenosine Triphosphate (ATP) M easurement
The ApoGlow screening kit is an effective research tool that differentiates between 
apoptosis and necrosis by detecting the ratio of ADP to ATP. Therefore, ATP 
concentrations in cells were determined luminometrically using the ApoGlow assay kit, 
as described by the manufacturer (Lumitech, UK). Cells were then treated with a range of
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doses o f  H20 2. After H20 2 treatment cells were incubated with 150 jal o f nucleotide 
releasing agent per sample and allowed to equilibrate at room temperature for 5 min. 
Twenty jxl o f  nucleotide monitoring reagent was added and the first reading was recorded 
in the luminometer (Streptech) to determine ATP concentrations (i.e. Figure 2.2, reading 
A). After 10 min, 20 jal o f ADP converting reagent was added and luminescence was read 
(reading B). The final reading was performed 5 min later (reading C). ADP 
concentrations were calculated as C-B. ADP/ATP ratios were calculated as (C-B)/A.
Reading A







Figure 2.2: Kinetics o f the ApoGlow Kit. It illustrates an example o f the fold change in 
the ATP levels.
2.7 LIP determination by Fluorescence calcein assay (CA-assay)
The level o f LIP was estimated by a modification o f the method developed by 
Epsztejn et al (1997). The principle o f this assay is that the fluorescent CA, formed
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intracellulary upon cellular loading with the nonfluorescent precursor CA-AM (Figure 
2.2), binds to a fraction of the cellular iron associated with the LIP, thereby quenching its 
fluorescence. The level of intracellular CA-bound iron was determined by the increase in 
fluorescence produced by the addition of the iron chelator SIH, Figure 2.2). A schematic 
representation of the CA-fluorescent measurement in the spectrofluorometer is shown in 
Figure 2.3.
Immediately after UVA or H2O2 treatments cells were loaded with 0.05 pM calcein- 
AM in 1 ml Earle’s minimum essential media (containing 20 mM HEPES, pH 7.3) for 15 
min at 37°C. Then cells were washed with PBS and resuspended in 10 mM HEPES 
buffer containing 2 mM diethyltriamine-pentaacetic acid. The cell suspension was 
transferred to a thermostatically controlled cuvette and CA fluorescence was monitored 
on a spectrofluorimeter with excitation at 480 nm and emission at 517 nm. The level of 
intracellular calcein-bound iron (CA-Fe) was measured by the increase in fluorescence 
signal after the addition of SIH (40 pM, final concentration).
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Figure 2.3: Schematic representation of the change in fluorescence after the addition of the iron 
chelator, SIH. F represents free CA, AF represents CA-Fe and Ftotai is the total fluorescence 
representing free CA + CA-Fe. 70
In order to obtain the relationship between the changes in fluorescence elicited by SIH 
and LIP in cells, calibrations were performed in untreated cells. Firstly, the relationship 
between fluorescence intensity of CA and intracellular iron concentration was performed 
by titration of CA-loaded cells via the addition of ferrous ammonium sulphate (FAS). 
Since FAS is a source of Fe2+, a divalent metal ionophore A23187 was added to 
internalise the compound. After treatment with 10 pM A23187, 0.1 pM FAS was added 
cumulatively and the corresponding change in fluorescence was determined.
Secondly, the determination of dissociation constant (Kd) of calcein-bound iron was 
also required so that the free iron concentration in the cells could be calculated. The 
dissociation constant was calculated with a 5 pM CA solution and was based on the 
titration of CA-loaded cells with FAS. From the titration, the free CA fluorescence 
intensity was first normalised to the initial fluorescence value and then plotted against the 
metal concentration.
Finally, the cell volume was also considered. Cell volume was measured by using a 
certain amount of cell suspension (12 x 106). The cells were resuspended in 200 pi PBS, 
transferred into the capillary tubes, sealed with Cristasel, and centrifuged at 1000 rpm for 
1 min in a Hameatocrit centrifuge GIBA-GEIGY TH12. The cell volume was calculated 
by using the percentage of cell packed volume divided by the number of cells.
71
0II DI t
(CH3 COCRa OCCH2 L>rji
o  o
II M




(B): Salicylaldehyde isonicotinoyl hydrazone (SIH) 
Figure 2.2: Chemical structures of calcein (A) and SIH (B).
2.8 Ferritin ELISA
The level of Ft after different treatments was determined using a polyclonal (anti­
ferritin) enzyme-linked immunosorbent assay (ELISA) kit known as Enzyme-Test® 
Ferritin kit (Roche, UK). For this assay, cytosolic extracts are prepared and added to a 
streptavidin tube along with biotinylated monoclonal, mouse anti-Ft antibodies, labelled 
with peroxidase (the incubation solution). The antibodies bind to streptavidin, thus 
anchoring the ferritin/antibody complexes to the tube. Next, a peroxidase substract, 
ABTS® (di-ammonium 2, 2’-azino bis 3-ethylbenzothiazoline-6-sulphonate), is added 
and is cleaved by the peroxidase to produce a characteristic green colour, which is 
measured spectrophotometrically at 420 nm. Ferritin levels were expressed as ng ferritin 
per mg of protein.
2.8.1 Preparation of cytosolic extracts
Cells were collected at 3xl06 cells/ml after the treatments and washed in ice-cold 
PBS. The cells were re-suspended in lx  Munro lysis buffer [10 mM Hepes at pH 7.5, 3 
mM MgCE, 40 mM KC1, 5% glycerol, chymostatin (50 pg/ml) and 0.3% NP-40 (Merck, 
UK)] and flash-frozen in dry-ice with 96% Ethanol. Cell extracts were then stored at - 
70°C till use.
2.8.2 Protein measurement
Cytosolic protein concentration was determined by Bradford assay with the BioRad 
reagent kit (Bradford, 1976). A series of concentrations of BSA (100 mg/ml, stock) were 
made from 0 to 25 jug/ml for the calibration of standard curve and absorbance
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measurements obtained using a 96-well microplate reader (Dynatech MR5000) at 595 
nm. Measurements were performed in duplicate on 10 pi aliquots of the extracts and the 
mean values were obtained from duplicate experiments.
2.8.3 Ferritin analysis
Ferritin standards and cell extracts were added to streptavidin-coated tubes with the 
incubation buffer (containing anti-ferritin antibodies) and incubated at room temperature 
(RT) for 30 min. The tube contents were then aspirated and rinsed with washing solution.
/B\
The chromogen substrate solution (ABTS ) was then added to each tube and incubated 
for 15 min at RT. The absorbance was measured immediately at 420 nm using the 
spectrophotometer (UNIKON 922, Switzerland). The Ft concentration in each extract 
was determined against the ferritin standards and normalised using the total cytosolic 
protein concentration obtained from the Bradford assay.
2.9 Metabolic labelling in cells
Biosynthesis of Ft protein under control, hemin or DFO stimulated and UVA- or 
H2O2- treated conditions was evaluated by means of metabolic labelling using
35 7[ SJmethionine. Briefly, 2 x 1 0  cells per sample per time-point were starved for 30min 
in methionine-free minimum essential media supplemented with 5% FCS followed by 
[ S]methionine labelling (7 pCi/ml) for lh  30min. The cells were then treated with 
either UVA or H2O2, depending on the conditions, apart from hemin and DFO treatments 
in which hemin or DFO were always present, during starvation and labelling of the cells. 
Cells were then lysed in immunoprecipitation buffer (50 mM Tris, pH 7.4 / 150 mM
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NaCl / 10 mM EDTA / 1% Triton X-100 / 1% SDS / lx cocktail o f protease inhibitors / 
20 pg/ml leupeptin and 100 pg/ml chymostatin). The efficiency of metabolic labelling 
was monitored by trichloroacetic acid (TCA) precipitation, since it is used for 
monitoring the incorporation of radioactivity into cellular proteins. Equal amounts of 
labelled proteins were then immunoprecipitated by using either anti-human ferritin 
polyclonal antibody, followed by Protein G-sepharose and loaded on a 12% SDS- 
polyacrylamide gel. Gel run overnight at 40 V and then fixed with 100 ml isopropanol, 
40 ml acetic acid and 260 ml water for 30 min and dried. After drying, the gel was 
exposed for autoradiography.
2.10 Western blotting
Western blotting was used for the identification and semi-quantification of specific 
proteins, which have been separated according to their size by SDS-Polyacrylamide gel 
electrophoresis (SDS-PAGE). After different treatments and post-incubation times, cells 
were lysed with 1 x Munroe lysis buffer (10 mM Hepes pH 7.5, 3 mM MgCl2, 40 mM 
KC1, 5% glycerol, 0.3% NP40, 50 jug/ml pefablock and MilliQ water to get 1 ml final
n
volume per 3 x 10 cells). Protein measurement was then determined as described in 
section 2.8.2.
Equal amounts of protein (30 jug per condition) were diluted with 3 x loading buffer 
[180 mM Tris, pH6.8 / 3% SDS / 150 mM DTT (1,4-dithio-DL-threitol) / 30% glycerol / 
0.0015% bromophenol blue / 0.53 ml milliQ water] and boiled for 5 min. Proteins were 
separated on a 10% polyacrylamide gel and electrotransferred onto nitrocellulose 
membranes using BioRad electro-transfer unit. Membranes were stained with red
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ponceau c to ensure equal loading and transfer of protein. Membranes were then blocked 
for lh  30 min (room temperature) with 5% milk powder in 0.05% Tween-PBS for HO-1 
antibody and with 3% milk powder, 3% BSA in 0.1% Tween-PBS for actin antibody. 
After blocking, membranes were incubated overnight (4°C) with 1:1000 polyclonal HO-1 
antibody (goat polyclonal IgG) or for lh  30 min (room temperature) with 1:500 
monoclonal actin antibody (produced in mouse). After incubation period of primary 
antibody, membranes were washed with Tween-PBS for three times every 10 min. 
Membranes were then incubated with 1:1000 anti-goat IgG HRP antibody for HO-1 or 
1:2500 anti-mouse Ig HRP antibody for actin, for lh  at room temperature. 
Immunoreactive bands were visualised with the enhanced chemiluminescence detection 
system by Amersham Biosciences.
2.11 Measurement of HO-1 expression by Flow cytometry
Flow cytometric analysis was used for the detection of expression of HO-1 in both 
control and hemin stimulated parental and H2O2 resistant cells. Briefly, 1 x 106 cells were 
treated with hemin for different time points (2, 4, 6 and 8 hours). After treatment cells 
were fixed in 1 ml of 70% ice-cold ethanol. Cells were blocked with 500 ml bovine 
serum albumin (BSA) for 10 min at 37°C. After blocking, cells were incubated with 
mouse anti-HOl monoclonal antibody in the dark for 60 min. After incubation of primary 
antibody cells were washed twice with PBS and incubated with an anti-mouse FITC 
antibody in dark for 60 min. Cells were then washed twice with PBS and resuspended in 
300 pi PBS for flow cytometric analysis. A minimum of 10,000 cells were analysed per 
sample on a FACSvanatge (Becton Dickinson, Erembodegen, Belgium). The following
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settings were used for all the analysed cell lines: FL1 (530 ± 1 5  nm) in log data 
collection. The data were analysed using FL1 fluorescent profiles. Data analysis was 
performed with CellQuest software (Becton-Dickinson, Erembodegem, Belgium).
2.12 Catalase activity assay
Catalase activity in both normal and H2O2 resistant cells was quantified by a 
modification of the method developed by Moysan et al (1993). This assay is based on the 
direct decomposition of H2O2 to ground state oxygen and water without the use of 
another substrate as GPx does. Therefore, catalase activity is estimated by the direct 
measurement of H2O2 consumption.
Cells (1 x 106) were lysed in 225 pi of phosphate buffer (50 mM KHPO4, pH 7.5), to 
which 25 j l l I  Triton X I00 (0.1% final concentration) was mixed. The suspension was 
sonicated on ice for 60 sec at high strength (Branson B-12 sonifier,Branson Sonic Power, 
Danbury, CT) and spun at 13000 rpm for 3 min. The clear supernatant was collected and 
used for the assay. Next, 100 pi of the lysate was mixed at 25 °C with 600 pi H2O2 (10 
mM solution in phosphate buffer). Hydrogen peroxide consumption was then monitored 
spectrophotometrically at 240 nm using a thermostatically controlled quartz cuvette 
(25°C) for 1 to 2 min. Catalase activity was normalised to sample protein content (protein 
was measured by Bradford assay, see 2.7.2) and expressed as Unit per mg (U/mg) 
protein. One unit (U) is defined as 1 pmole H2O2 consumed per min.
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2.13 Glutathione peroxidase (GPx) activity assay
The GPx activity in both normal and H2O2 resistant cells was measured according to 
the method developed by Flohe and Gunzler (1984), with a few modifications. The 
principle of this assay is that GPx metabolises H2O2 by reduction of GSH resulting in the 
formation of water. The oxidised glutathione (GSSG) is reduced to GSH by glutathione 
reductase (GR) in the presence of NADPH. Thus, GPx activity is determined 
spectrophotometrically by the decrease in NADPH concentration.
2GSH + H20 2 - * -► GSSG + 2H20
GSSG + H+ + NADPH GR ► 2GSH + NADP+
Cells (lxlO6) were lysed in 500 pi of buffer (100 mM tris-HCl, 300 mM KC1, 0.1% 
peroxide-free Triton X I00, pH 7,6) by sonication. The cells were pelleted at 4000 rpm 
for 10 min and the clear supernatant was collected. A test mix containing 100 mM Tris- 
HCl (pH 7.6), 5 mM EDTA, 3 mM GSH, 0.2 mM NADPH, 0.1% Triton X100, 600 
mU/ml GR, was prepared and preincubated at 37°C for 10 min. The reaction started by 
the addition of 10 pi tert-butyl hydroperoxide (50 pM final concentration) and the 
NADPH consumption rate was spectrophotometrically measured at 340 nm for 5 min. 
GPx activity was normalised to sample protein content (protein was measured by 
Bradford assay, see 2.7.2) and expressed as U/mg protein. One unit was defined as 1 
pmole NADPH oxidised per min.
2.14 Glutathione (GSH) measurement
Glutathione is conveniently assayed by an enzymatic recycling procedure where it is 
sequentially oxidized by DTNB (Ellman’s reagent, 5,5’-dithiobis(2-nitrobenzoic acid))
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and reduced by NADPH, in the presence of GR (Tietze, F. 1969). The resulting product 
2-nitro-5-thiobenzoic acid (chromogenic) was spectrophotometrically measured at 412nm 
for 6-10 min and the glutathione present in cells is evaluated by comparison of the 
resulting values with the standard curve. This assay determines both GSH and GSSG.
GSSG + NADPH + H * ► 2GSH + NADP+
For the standard curve, GSSG stock solution is diluted in 5% TCA / 2 mM EDTA in a 
range of 0.01 -  2 |nM. For the samples, after treatment of cells with 50 jliM  of BSO, cell 
pellets were resuspended with 5% TCA / 2 mM EDTA in order to give 1ml of extract per 
2 x 106 cells.
For the assay, 1 ml phosphate-buffer EDTA was mixed with 20 pi DTNB (1.5 mg/ml 
in 0.5% NaHC03), 50 pi NADPH (5 mM in 0.5% NaHCOs) and 100 pi samples from 
either treated cells or GSSG samples for the standard curve in an eppendorf tube and 
transferred to a thermostatically controlled cuvette at 25 °C. To the prewarmed mixture, 
100 ml GR (18 u/ml in phosphate buffer) was added and the change in absorbance was 
monitored in the spectrophotometer for 6-10 min at 412 nm (25°C).
2.15 Total RNA preparation
Total RNA was extracted from control, H2O2 and UVA treated samples using Trizol. 
Cell pellets were treated with chloroform/isoamyl alcohol (49:1) in order to separate the 
organic and aqueous phase, which contains the nucleic acids. Aqueous phase was then 
transferred to a fresh eppendorf tube and an equal volume of isopropanol was added to 
the tube for precipitation. Samples were then centrifuged and the RNA pellet was washed 
with 75% cold-ethanol and left to dry. The RNA pellet was re-suspended in RNase-free
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water and RNA measurement was carried out spectrophotometrically at 260 nm and the 
calculations were performed according to the following equation:
Absorbance 260 x 201 (dilution factor) x 40 = RNA concentration in pg/ml.
2.15.1 Reverse transcriptase-PCR fRT-PCR)
Reverse transcriptase-PCR was performed for each RNA sample using the GeneAmp 
PCR system 2400 for first strand cDNA synthesis. Both RT-positive and RT-negative 
samples were prepared containing 1 pg total RNA in a final volume of 8 pi with water. 
Only the RT-positive samples were containing 2 pi of 50 pM poly d(T)i2-i8 to give a final 
volume of 5 pM. The reaction mix used for RT-PCR is shown in Table 2.1. Reaction 
components for RT-positive and RT-negative samples were set-up separately. RT- 
positive samples were denatured in PCR machine for 10 min at 70°C and chilled 
immediately on ice. After that 8 pi of the reaction mix was added in all samples (RT- 
positive and RT-negative) followed by reverse transcription at 42°C for 60 min, then 
95°C for 5 min and held at 4°C. The newly synthesised cDNA was stored at -80°C till 
used.
2.15.2 Polymerase chain reaction (PCR)
The aim of this step is to use the PCR primers to amplify the gene of interest. For 
each target cDNA one master mix was prepared (shown in Table 2.2) that contained one 
set of specific forward (Pi) and reverse (P2) primers. In this study, the housekeeping gene 
P-actin was used as control to estimate the amount of HO-1, mxr, mdr-1 and mrp-1 
cDNAs in each sample, p-actin primers (Pp 5’ CAT CAC CAT TGG CAA TGA GC 3’
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and P2: 5’ ATA CTC CTG CTT GCT GAT CC 3’), HO-1 primers (Pi: 5’ CCT TGT TGA 
CAC GGC CAT GAC CAC 3’ and P2: 5’ AGT TAG ACC AAG GCC ACA GTG CCG 
3’), mxr primers (Pi: 5’ TGC CCA GGA CTC AAT GCA ACA G 3’ and P2: 5’ GAC 
TGA AGG GCT ACT AAC C 3’), mdr-1 primers (P,: 5’ CAG ACA GCA GCT GAC 
AGT CCA AGA ACA GGA CT 3’ AND P2: 5’ GCC TGG CAG CTG GAA GAC AAA 
TAC ACA AAA TT 3’) and mrp-1 primers (P,: 5’ CGG AAA CCA TCC ACG ACC 
CTA ATC C 3’ and P2: 5’ TCC ACC TCC TCA TTC GCA TCC ACC TTG G 3’) were 
used to amplify cDNAs obtained from the same total RNA. PCR programme was set 
depending on the primers used, as detailed below:
• P-actin: initial denaturation step 5 min at 94°C, then 30 cycles of 30 sec at 56°C 
(annealing step) and 1 min at 70°C (elongation step). Final elongation step 7 min at 
72°C and held at 4°C.
• HO-1: initial denaturation step 5 min at 95°C, then 35 cycles of 30 sec at 52°C 
(annealing step) and 1 min at 72°C (elongation step). Final elongation step 7 min at 
72°C and held at 4°C.
• mdrl: initial denaturation step 5 min at 95 °C, then 30 cycles of 45 sec at 95 °C
(denaturation step), 1 min at 52°C (annealing step), 1 min and 30 sec at 72°C
(elongation step). Final elongation step 7 min at 72°C and held at 4°C.
• mxr: initial denaturation step 5 min at 95°C, then 30 cycles of 30 sec at 95°C
(denaturation step), 30 sec at 55°C (annealing step) and 3 min at 72°C (elongation 
step). Final elongation step 7 min at 72°C and held at 4°C.
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• mrpl: initial denaturation step 5 min at 95°C, then 30 cycles of 45 sec at 95°C 
(denaturation step), 1 min at 55°C (annealing step), 3 min at 72°C (elongation step). 
Final elongation step 7 min at 72°C and held at 4°C.
PCR amplified DNA products were evaluated by agarose gel electrophoresis (section 
2.15.3). In order to check for genomic contamination RT-negative samples were used and 
a water control was used for any possible DNA contamination. For the quantification of 
the mxr and mdr-1 genes cDNA probes were used as positive controls at a copy range of 
4.4 x 106 (MWG Biotech, UK).
2.15.3 Agarose Gel Electrophoresis
Gel electrophoresis was performed as described by Sambrook et al (1989). For fine 
separation and analysis of DNA, 2% agarose with 1 mg/ml ethidium bromide was loaded 
with 15 |l l 1 of each PCR sample, diluted with 5x loading buffer [300 mM Tris, pH6.8 / 5% 
SDS / 250 mM DTT / 50% glycerol / 0.0025% bromophenol blue / 0.88 ml milliQ 
water]. Gel was run with 0.5x TBE (for 1 litre: 54 g Tris-base, 27.5 g boric acid and 20 
ml 0.5 M EDTA, ph 8.0) buffer at 100 volts for 2 hours. The samples were then 
visualised using UV translluminator and the GeneGenius gel documentation and analysis 
system (Syngene Ltd).
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Reactants Stock Amount Final Concentration
RT Buffer 5 x 4 pi 1 X
DTT 100 mM 1 pi 5 mM
dNTP mix 10 mM 1 pi 500 pM
Rnasin 50 U/jliI 1 pi 2.5 U/pl
Superscript II 200 U/pl 1 pi lOU/pl
Table 2.1: Protocol for the RT-PCR reaction mix of total RNA using Superscript II.
Reactants Stock Amount Final Concentration
PCR buffer with Mg2+ 10 x 2.5 pi 1 X
dNTP mix 10 mM 0.6 pi 200 pM
Expand polymarase 3.5 U/pl 0.15 pi 0.05 U/pl
Pi + P2 prim ers 5 pM 3 pi + 3 pi 500 nM
cDNA - 2 pi -
W ater - 13.75 pi -
Table 2.2: Protocol for the PCR reaction mix using expand polymerase.
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2.16 Real time PCR -  Light Cycler®
Light cycler real time PCR system (Roche Molecular Biochemicals, Germany) is an 
extremely powerful tool for quantitative PCR with the use of a double-stranded (ds) DNA 
binding dye, SYBR Green I (Roche Molecular Biochemicals, Germany), which 
fluoresces only when bound to dsDNA. The fluorescence is recorded by the end of the 
elongation phase at 530 nm and increasing amounts of PCR product are monitored. In 
addition, determination of the melting temperature (Tm) of PCR products with SYBR 
Green I confirms product identity and differentiation from non-specific products such as 
primers-dimers. Therefore, real time PCR was used to amplify HO-1 using p-actin as 
control.
All reactions were carried out in a total volume of 20 pi. Each reaction mixture 
contained 2 pi of lOx SYBR Green I dye, 2 pi cDNA, 25 mM MgCL, 5 pM of both 
forward and reverse primers and water to make-up to 20 pi. For the amplification step the 
conditions were the same with PCR, see section 2.14.2, except from the cycle number 
that it was set to be 40 for the Light cycler conditions. Melting curve analysis consisted 
of 1 cycle of 95°C with 0 sec hold, 65°C with 15 sec hold and 95°C with 0 sec hold and 
continuous acquisition mode.
For quantification of each PCR product, a standard curve (i.e. Figure 3.3) was 
produced using a range of different concentrations of p-actin and HO-1 positive cDNA 
samples ranging from 1 to 10 ng of cDNA.
The real-time fluorescence signal generated by the SYBR Green I dye was quantified
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in the analysis screen o f the light cycler software. The software used the intersection 
between each fluorescence curve and a crossing line, to give a value for a crossing point. 
The crossing point valued for a set o f standards and was plotted to give a standard curve. 
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Figure 3.3: Representation o f the Light Cycler® software for the analysis and calculation 
o f  the concentrations o f  the gene o f interest in different samples. The software calculates 
the concentration o f target molecules by plotting logarithm o f fluorescence versus cycle 
number and setting a baseline x-axis (A). The baseline identifies the cycle in which the 
log-linear signal can be distinguished from the background for each sample (A). The x- 
axis crossing point o f each standard is measured and plotted against the logarithm of 
concentration to produce standard curve (B). The concentration o f target sequence in the 
samples are extrapolated from the standard curve.
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2.17 Flow Cytometric detection of functional dye/drug efflux
The modulation of drug efflux by 10 pmole/L verapamil was studied on flow 
cytometry using the fluorescent dye 3,3'-diethyloxacarbocyanine iodide (DiOC2(3)), an 
established substrate for PgP.
Normal and H2C>2-resistant cells were resuspended with Dulbeco’s Minimun Essential 
medium (DMEM), without phenol red, supplied with 10% FCS. Five samples per cell 
line were prepared: first sample (resuspended in PBS) was kept on ice as a control, rest of 
the samples (1 x 106 cells per sample) were resuspended with 1 ml DMEM + 10% FCS 
containing 2 pi of 30 pg/pl DiOC2(3) and only one of the samples had 10 pi of 1 mM 
verapamil. All samples were incubated for 30 min at 37°C (dark conditions). After 
incubation, samples were washed with ice cold PBS and the two samples with DIOC2(3) 
and DIOC2(3) + verapamil, were kept on ice for immediate measurement of baseline 
DIOC2(3) uptake. The rest two of the samples were resuspended with 1 ml DMEM + 
10% FCS containing 2 pi of 30 pg/pl DiOC2(3) and only one of the samples had 10 pi of 
1 mM verapamil. Samples were incubated for 90 minutes at 37°C to allow time for active 
efflux to occur. After efflux, cells were washed and resuspended in PBS. As a positive 
control for this study, a human T-lymphoblastic CEM and its vinblastine-resistant 
subclone CEM/VLBioo (Beck et al, 1979, Foley et al, 1965) leukemia cell lines were 
used.
DiOC2(3) is excited at a wavelength of 488 nm and emits at 500 nm. Therefore, 




Results are expressed as mean ± standard deviation (SD). Paired or unpaired 
Student’s one-tailed /-test was used as appropriate to test differences between groups of 
data. Note that the rejection p value is 0.05. All analyses were carried out using Microsoft 




3.1 Effects of H2O2 treatment and UVA radiation on the cell survival
Hydrogen peroxide is toxic to most o f the cells and, as a ROS, is involved in 
propagation o f cellular damage due to its reactivity towards lipids, proteins and DNA 
(e.g. Brunk et al., 1995). The major intracellular anti-oxidant enzymes catalase and 
GPX usually act upon H2O2 to either directly break it down to water and oxygen or to 
convert it to water and alcohol via oxidation of GSH (see Section 1.6).
UVA, the oxidizing component of sunlight is also harmful to cells as it generates 
ROS in cells via interaction with intracellular chromophores promoting biological 
damage in exposed tissues (Black, 1987; Trenam et al., 1992; Yasui et al., 2000). 
Several studies have demonstrated that both non-enzymatic and enzymatic anti­
oxidant systems could significantly decrease the oxidative stress generated by UVA 
(see Tyrrell, R.M. 1991 and 1996).
However if  cells are exposed to a severe oxidative insult, the anti-oxidant defence 
mechanism often does not suffice to counteract the oxidative imbalance in cells and as 
a result cells will die by either o f two distinct mechanisms, necrosis (unordered and 
accidental form of cellular dying) or apoptosis (programmed and managed form of 
cell death). It has also been observed in some cases that an oxidizing insult could 
promote simultaneously both apoptotic and necrotic cell death (see Reed et al, 1999
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and unpublished data, this laboratory). Since apoptosis and necrosis are considered 
conceptually and morphologically distinct forms of cell death, it is not clear how the 
same initial insult decides the prevalence o f either phenomenon. Recent unpublished 
data from this laboratory provide strong evidence that UVA-induced immediate 
increase in LIP reflects the extent o f necrotic cell death in both human skin fibroblasts 
and keratinocytes. Since exposure o f skin cells to H2O2 also promotes labile iron 
release, it is reasonable to suggest that this phenomenon may also be linked to 
increased susceptibility o f cells to necrotic cell death.
Our cell model o f parental and H2O2 resistant Jurkat T cells provided us with an 
opportunity to investigate further these phenomena by first looking at how 
intracellular anti-oxidant defence mechanisms might play a role in adapting cells to a 
source o f oxidative stress. Next, the possible role o f labile iron, heme, Ft and HO-1 in 
increasing the resistance of cells to H2O2 was investigated.
Sections 3.1 to 3.8 provide an in depth comparison o f these parameters between 
the parental and H2O2 resistant cell lines following treatment with the oxidizing 
agents H2O2 and UVA radiation.
3.1.1 Determination o f the level o f FLO? resistance
To evaluate the level of resistance o f both parental and H2O2 resistant cells to 
H2O2, the level o f apoptotic and necrotic cell death were scored by flow cytometry 
using the dual Annexin V/PI staining method (see section 2.4). For this purpose, cells 
were first treated with a range o f doses o f H2O2 and then incubated for either 4 or 24 h 
at 37°C prior to analysis by flow cytometry. The results o f 4 h post-treatment revealed 
that in cells treated with low doses o f H2O2 (i.e. up to 0.5 mM) no significant 
difference in cell survival could be observed between the parental and H2O2 resistant
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cell line (Figure 3.1). However, at higher doses o f H2O2 (i.e. 1 and 3mM), the 
percentages o f live cells were significantly higher in H2O2 resistant cells when 
compared to parental cells. The higher resistance o f H2O2 resistant cells to H2O2 
became even more apparent when the treated cells were incubated for a longer period 
(i.e. 24 h post-treatment) prior to flow cytometric analysis. Indeed, we observed that 
24 h following H2O2 treatment, the percentage o f live cells drops dramatically in 
parental cells when compared to H2O2 resistant cells (Figure 3.2). In particular, the 
difference in percentage o f live cells between 0.5 to 1 mM H2O2 treated parental and 
H2O2 resistant cells was significant (f, p<0.05). In parental cells, the drop in 
percentage o f live cells coincided with a reciprocal increase in the percentage of 
necrotic cells. On the other hand, in H2O2 resistant cells, necrosis occurred to a lesser 
extent when compared to parental cells, confirming the resistance o f cells to H2O2 up 
to final concentration o f 1 mM. The difference in the percentage o f necrotic cells 
between the two cell lines (*, p<0.05) was also statistically significant. Interestingly, 
the level o f apoptosis was low in both cell lines, indicating that necrosis is the primary 
mode o f cell death induced by H2O2.
3.1.2 Effects o f UVA on the induction o f cell death
To examine whether cells resistant to H2O2 are also resistant to UVA radiation, 
both cell lines were treated with UVA doses o f 100, 250 and 500 kJ/m2. After UVA 
radiation cells were incubated for either 4 or 24 h in conditioned media and then the 
level o f apoptotic and necrotic cells were scored by flow cytometry. The results 
showed that at both 4 (Figure 3.3) and 24 h (Figure 3.4) post-UVA treatment, there 
was no significant difference in cell survival between parental and H2O2 cell lines. 
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Figure 3.1: Effect o f different H20 2 doses on the survival of parental (A) and H20 2 resistant (B), Jurkat 
cells.
Note: Cells were incubated for 4 h post-treatment prior to dual Annexin V / PI staining and flow cytometric analysis. 
Mean ± SD (n = 3)
NS : p>  0.05, no significant difference between parental and H20 2 resistant cells at corresponding H20 2 
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Figure 3.2: Effect of different H2O2 doses on the survival of parental (A-24 h) and H2O2 resistant (B-24 h), 
Jurkat cells.
Note: Cells were incubated for 24 h post-treatment prior to dual Annexin V / PI staining and flow cytometric analysis. 
Mean ± SD (n = 3)
t  : p<0.05, significant difference between parental and H2O2 resistant cells at corresponding H2O2 doses 
(live cells)
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Figure 3.3: Effect o f UVA (kJ/m2) on the survival of parental (A) and H2O2 resistant (B), Jurkat cells. 
Note: Cells were incubated for 4 h post-irradiation prior to dual Annexin V / PI staining and flow cytometric 
analysis.
Mean ± SD (n = 3-4)
































Figure 3.4: Effect o f UVA (kJ/m2) on the survival of parental (A) and H2O2 resistant (B), Jurkat cells. 
Note: Cells were incubated for 24 h post-irradiation prior to dual Annexin V / PI staining and flow cytometric 
analysis.
Mean ± SD (n = 3-4)
NS : p > 0.05, no significant difference between parental and UVA resistant cells at corresponded UVA 
doses
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observed either 4 or 24 h following radiation treatment. Furthermore, at both time 
points, the percentages o f apoptotic cells were very low. Overall, these data indicate 
that Jurkat cells resistant to H2O2 are not resistant to UVA radiation. Moreover, these 
data strongly suggest that the primary mode o f cell death after exposure o f cells to 
UVA or H2O2 is necrosis.
3.2 The role of intracellular ATP concentration on the switch between apoptosis 
and necrosis.
Progression o f death stimuli to necrosis and apoptosis depends on the effect the 
mitochondrial damage has on cellular ATP levels (see Reed, 1998; Leist et al, 1997; 
Ha and Snyder, 1999). Apoptosis is an energy driven process and ATP is essential to 
the early events of apoptosis. In contrast ATP depletion triggers necrosis (see section 
1.8). To assess the correlation between the percentage o f H2C>2-mediated necrosis in 
cells (i.e. measured by flow cytometry) and the extent of intracellular ATP depletion, 
Apoglow kit (see section 2.6) was used to monitor the modulation o f the intracellular 
level o f ATP following treatment o f both cell lines with H2O2.
The results in Figure 3.5 revealed that H2O2 promotes immediate depletion o f 
ATP in both cell lines in a dose dependent manner as measured within the first 5 min 
following oxidative insult. Furthermore, ATP depletion does not follow an increase in 
ADP concentration neither at 10 or 15 min after the addition o f the ADP converting 
reagent indicating that the mode o f cell death is predominantly via necrosis. Although, 
ATP depletion occurred in both cell lines after a range o f H2O2 doses, it appears that 
the decrease in ATP levels in H2O2 resistant cells occurs to a lesser extent than in 
parental cells consistent with the notion that H2O2 resistant cells are more resistant to
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necrosis than parental cells at both 4 and 24 h time points (Figure 3.6). These data are 





S 0 7  
0.6























Figure 3.5: A representation o f the fold change in ATP release at 4 h after treatment o f both parental 
(A) and H20 2 resistant (B) cells with a range of doses o f  H20 2 using the ApoGlow kit as detailed in 
section 2.6.
Mean ± SD (n = 3)
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Figure 3.6: Fold change in ATP levels at 4 h (A) and 24 h (B) after a range of doses of H2O2 treatment in 
both parental and H2O2 resistant cells.
Mean ± SD (n = 3)
* : p<0.05, significant difference between parental and H2O2 resistant cells at both 4 and 24h time points.
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3.3 The role of anti-oxidant enzymes
It is well established that most o f the H2O2 in cells is eliminated by intracellular 
antioxidant enzymes catalase and GPx. In addition, GSH is present in high 
concentrations in many cell types and is expected to be important in cellular defence. 
Thus the role o f these anti-oxidant enzymes in resistance o f cells to H2O2 was 
investigated.
3.3.1 The role o f catalase activity
To investigate whether higher catalase activity in cells is related to the higher 
resistance o f cells to H2O2, the basal level of catalase activity was determined 
spectrophotometrically by following the rate o f H2O2 consumption as detailed in 
section 2.11. The results (Table 3.1) showed no significant difference in the level of 
catalase activity between both parental and H2O2 resistant cells, suggesting that there 
is no correlation between this enzymatic activity and the resistance o f cells to H2O2.
3.3.2 The role o f glutathione peroxidase (GPx)
In addition to catalase, the level o f activity o f GPx, another KhCVdetoxyfying 
enzyme, was measured (see section 2.12), in both parental and H2O2 resistant cells. 
The results (Table 3.2) showed that the activity of GPx is significantly different 
between the parental and H2O2 resistant cells (*, p<0.05). Indeed the GPx activity in 
H2O2 resistant cells (124.69 ± 24.59) was up to 1.5 fold higher as compared to the 
parental cells (88.25 ± 14.67).
Taken together these data indicate that higher GPx activity in H2O2 resistant cells 
might play a role in the resistance o f cells to H2O2.
99
Table 3.1: Assessment of catalase activity (u / mg protein) based on H2O2 consumption, in both 
parental and H2O2 resistant Jurkat cells.
Cell Line Catalase activity 
(u per mg protein)
Fold difference
Parental cells 0.35 ±0.12 1
H2O2 resistant cells 0.29 ±0.11 NS 1.2 ±0.02
the cells as described in sectionNote: Catalase activity was measured immediately after lysis o 
2 . 12.
Mean ± SD (n = 4)
NS : p> 0.05, no significant difference between parental and H2o 2 resistant cells
Table 3.2: Assessment of GPx activity based on NADPH consumption rate (u / mg protein) in both 
parental and H2O2 resistant Jurkat cells.
Cell line GPx activity (u per mg protein)
Fold difference
Parental cells 88.25 ± 14.67 1
H2O2 resistant cells 124.69 ±24.59* 1.42 ±0.21
Note: GPx activity was measured immediately after treatment of the cells as described in section 
2.13.
Mean ± SD (n = 5)
* :p< 0.05, significant difference between normal and H20 2 resistant cells
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3.3.3 The role of glutathione (GSH)
Previous evidences from this laboratory have suggested that GSH plays a critical 
role as an anti-oxidant compound as depletion o f intracellular GSH with BSO was 
found to sensitise cells to the lethal action o f both UVA and UVB radiations as well 
as H2O2 (Tyrrell and Pidoux, 1986 and 1988, and unpublished data, this laboratory).
In this study, GSH levels were assessed with or without treatment o f both parental 
and H2O2 resistant cells with 50 pM  BSO for 18 h. The results (Table 3.3) showed 
that total GSH levels are 1.6 fold higher in H2O2 resistant cells when compared to the 
parental cells. Furthermore the 50 |iM  BSO completely abolished the level o f GSH in 
both parental and H2O2 resistant cells. These data strongly suggest that higher GSH in 
H2O2 resistant cells might play a role in their resistance to H2O2.
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Table 3.3: Assessment of GSH levels (pM) per mg total protein in both parental and H2O2 resistant 
Jurkat cells.
Total pM GSH per mg protein
Cell Line Control Fold difference 50 pM B S 0 18h
Parental cells 0.156 ±0.041 1 0.004 ± 0.0008
H 2O2 resistant 
cells
0.25 ±0.072* 1.6 ± 0 .0 5 0.002 ± 0.00006
Note: GSH levels were measured in untreated control and 50 pM BSO treated cells. The assay 
was carried out immediately after lysis of the cells and normalised using a standard curve of 
GSSG, as described in section 2.14.
Mean ± SD (n = 4)
* : p< 0.05, significant difference between parental and H2q 2 resistant cells at the control levels
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3.4 Effect on modulation of LIP levels in response to oxidant- induced damage.
Recent discoveries from our laboratory (Pourzand et al, 1999 and unpublished 
data, this laboratory) indicated that both UVA and H2O2 as oxidizing agents trigger 
the immediate increase in LIP within cultured human skin cells. The increase in LIP 
has also recently been linked in our laboratory to the increased susceptibility o f cells 
to necrotic cell death (unpublished data, this laboratory). These observations 
prompted us to characterise this phenomenon in our model o f human Jurkat T cells 
and to ask the question as to whether both ‘basal’or ‘oxidant-induced’ increase in LIP 
play a role in resistance o f Jurkat cells to UVA and H2O2 -  mediated necrotic cell 
death. Table 3.4 summarises the basal level concentration o f LIP in both cell lines of 
parental and H2O2 resistant, as determined by the Kd values with CA-assay for each 
cell line (see section 2.7). The results demonstrated that the basal level o f LIP were 
similar in both cell lines. The determination o f Kd values and the cell volume were 
required for calibration o f LIP concentration. The Kd values were not significantly 
different between parental (28.82 ± 5.06) and H2O2 resistant (20.06 ±2.51)  cells. In 
contrast, the cell volume o f H2O2 resistant cells (1.6 ± 0.19) was 2 fold higher than 
that of parental cells (0.85 ± 0.06).
3.4.1 The role o f LIP on the increased susceptibility of cells to PLO? resistance
Using the CA-assay (see the section 2.7), the LIP levels were measured 
immediately after H2O2 treatment o f both parental and H2O2 resistant cells with H2O2 
doses o f 0.05 to 3 mM. The results (Figure 3.7) revealed that following H2O2 
treatment with non-lethal doses o f H2O2 (i.e. 0.05 -  1 mM), the level o f LIP in both 
cell lines was increased in a dose-dependent manner. The comparison o f H2O2-
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mediated LIP release in both parental and H2O2 resistant cell lines revealed that the 
extent o f LIP release in parental cells was up to 3.5 fold higher than the H2O2 resistant 
cells. The latter difference in LIP release was more significant at the first three doses 
of H2O2 (i.e. 50, 100 and 500 jiM) treatment (*, p<0.05). Interestingly, when cells 
were exposed to 1 and 3 mM doses o f H2O2, the LIP levels began to decrease, 
presumably due to higher toxicity o f the doses applied (see Figure 3.2). These results 
strongly suggested a direct correlation between the level o f KhCVinduced labile iron 
release and the level o f resistance o f cells to H2O2.
3.4.2 The role o f LIP in response to UVA
To study the effect o f UVA on modulation o f LIP levels in both parental and H2O2 
resistant cells, cells were irradiated with UVA doses of 250 and 500 kJ/m2 and the 
change in LIP levels were then assessed by the CA-assay. The results (Figure 3.8) 
revealed that UVA triggers labile iron release in both cell lines in a dose-dependent 
manner. Indeed at a high dose of UVA (500 kJ/m2), the LIP levels were significantly 
higher in both treated cell lines when compared to the corresponding untreated control 
cells. However at a moderate dose o f 250 kJ/m , a significant increase in LIP was 
observed in H2O2 resistant cells when compared to the parental cells. Indeed 
following a UVA dose o f 250 kJ/m , labile iron release in H2O2 resistant cells was up 
to 2 fold higher than the parental cells (*, p<0.05). These data indicate that although 
UVA radiation induces labile iron release in both cell lines, the extent o f this 
phenomenon is much higher in H2O2 resistant cell line when compared to parental 
cells. So, these results clearly indicated that the effects o f H2O2 and UVA on the level 
o f LIP release are opposite in both parental and H2O2 resistant cells.
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Table 3.4: Determination of basal LIP in parental and H2O2 resistant Jurkat cells.
Cell line Cell Volume Kd value [LIP] pM
Parental cells 0.85 ± 0.006 28.82 ± 5.06 3.08 ± 0.59
H2O2 resistant cells 1.6 ± 0.19 20.06 ±2.51 3.34 ± 0.87
Note: The LIP concentrations are expressed as mean ±  SD (n=3-16). The cell volum e and Kd 
values are also expressed as mean ±  SD (n=3-6).
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Figure 3.7: Effect of H20 2 treatment on the concentration of LIP in both parental and H20 2 
resistant Jurkat cells. LIP determination was performed immediately after H20 2 treatment.
Mean ±  SD (n =3-8)
* : p<0.05, significant difference between parental and H20 2 resistant cells, at corresponding H20 2 
doses.
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Figure 3.8: Effect of UVA irradiation on the concentration of LIP in parental and H2O2 resistant Jurkat cells. 
Measurements were performed immediately after irradiation.
Mean ± SD (n = 3)
* : p<0.05, significant difference comparing parental and H202 resistant cells at the corresponding UVA dose, 
t  : p<0.05, significant different compared to untreated control in H2O2 resistant cells.
%\ p< 0 .05, significant different compared to untreated control in parental cells.
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3.5 The role of intracellu lar L IP level in m odulating the resistance of cells to
h 2o 2.
To assess the hypothesis that changes in the intracellular level o f labile iron might 
in turn modulate the resistance of cells to H2O2, cells were first incubated with either 
100 fiM DFO (iron chelation) or 20 |iM  hemin (iron loading) prior to treatment with 
H2O2. Next, the change in LIP was monitored by the CA assay and the level of 
resistance o f cells to H2O2 was assessed by both MTT and Annexin V/PI staining 
assays. The results are discussed below in sections 3.5.1 to 3.5.4.
3.5.1 Effects o f iron depletion on the cell survival
Parental and H2O2 resistant cells were first incubated for 18 h with 100 jiM DFO 
and then treated with a range o f doses o f H2O2. The assessment o f cell survival was 
performed by MTT assay 4 and 24 h following H2O2 treatment. The results revealed 
that in parental cells at both 4 (Figure 3.9) and 24 h (Figure 3.10) post-treatment time 
points, the percentage o f live cells in H2O2 + DFO treated cells was significantly 
higher (*, p<0.05) than in H2O2 treated cells alone. On the other hand, in H2O2 
resistant cells the protective effect o f DFO was only apparent at a high dose o f 3 mM.
We also evaluated the effect of DFO on the cell survival following UVA radiation 




[H20 2] + 100pM  DFO
100
(Ho






0 0.5 2 2.5 31 1.5
[H20 2]
[H20 2] + 100pM  DFO
H20 2 [mM]
Figure 3.9: Effect H20 2 ± DFO treatment on the survival of parental (A) and H20 2 resistant (B), Jurkat cells. 
Both cell lines were treated with 100 pM DFO for 18 h before H20 2 treatment. In both cell lines MTT assay 
was performed 4h following H20 2 treatment.
Mean ± SD (n=3)
* : p  < 0.05, significant difference between H20 2 treated and H20 2 + DFO treated, in parental cells 
t  : p  < 0.05, significant difference between H20 2 treated and H20 2 + DFO treated, in H20 2 resistant cells
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Figure 3.10: Effect H20 2 ± DFO treatment on the survival of parental (A-1 and B-1) and H20 2 resistant (A-2 
and B-2), Jurkat cells. Both cell lines were treated with 100 pM DFO for 18 h before H20 2 treatment. In both 
cell lines MTT assay (A-1 and A-2) and flow cytometric analysis (B-1 and B-2) were performed 24 h 
following H20 2 treatment.
Mean ± SD (n=3)
* : p  < 0.05, significant difference between H20 2 treated and H20 2 + DFO treated, in parental cells 
t  : p  < 0.05, significant difference between H20 2 treated and H20 2 + DFO treated, in H20 2 resistant cells
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incubated for 18h‘with 100 pM DFO and then irradiated with UVA doses o f 100, 250 
and 500 kJ/m . The MTT assay was performed 4 and 24 h following UVA radiation 
treatment. The results (Figure 3.11) demonstrated that DFO treatment per se does not 
affect the percentage of cell survival 4 h after UVA radiation in both cell lines. 
However, at 24 h post-treatment time point, the percentage o f live cells dropped 
dramatically in both UVA treated parental and H2O2 resistant cells (Figure 3.12) 
indicating that cells resistant to H2O2 are not necessarily resistant to UVA radiation. 
Since the percentage o f live cells was generally higher in DFO-treated cells, it was 
concluded that pre-treatment with DFO protects the parental and H2O2 resistant cells 
against UVA radiation.
3.5.2 Effects o f iron depletion on the levels o f LIP release
Treatment o f parental and H2O2 resistant cells with 100 pM DFO for 18 h 
completely abolished both the basal and the H202-induced levels o f LIP (Table 3.5). 
These results were in agreement with findings by Pourzand et al (1999) showing that 
treatment o f a human primary fibroblast cell line with DFO prior to UVA, can abolish 
both the basal and UVA-induced level o f LIP.
3.5.3 Effects o f iron loading on the cell survival
Parental and H2O2 resistant cells were first incubated for 18 h with 20 pM hemin 
prior to H2O2 treatment. The MTT assay was then performed (see section 2.5) 4 and 
24 h following H2O2 treatment. In addition to MTT assay, quantification of apoptosis 
and necrosis was also performed by the dual Annexin V/PI staining assay (see section 
2.4) 24 h following exposure o f both cell lines to H2O2. The MTT assay (Figure 3.13) 
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Figure 3.11: Effect o f UVA ± hemin ± DFO treatments on the survival of parental (A) and H2O2 resistant (B), 
Jurkat cells. Both cell lines were treated either with 20 pM hemin or with 100 pM DFO, for 18 h before UVA 
radiation. In both cell lines MTT assay was performed 4 h following UVA radiation.
Mean ± SD (n=3)
According to statistical analysis by Mest no significant difference was observed between UVA-treated and 
UVA + hemin or DFO treated, cells.
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Figure 3.12: Effect of UVA ± hemin ± DFO treatments on the survival of parental (A) and H2O2 resistant 
(B), Jurkat cells. Both cell lines were treated either with 20 pM hemin or with 100 pM DFO, for 18 h before 
UVA radiation. In both cell lines MTT assay was performed 24 h after UVA radiation.
Mean ± SD (n=3)
* : p  < 0.05, significant difference between UVA treated and H2O2 + hemin treated (in both cell lines) 
f  : p  < 0.05, significant difference between UVA treated and H2O2 + DFO treated (in both cell lines)
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Table 3.5: Determination of basal level of LIP in parental and H2O2 resistant Jurkat cells.
Cell line Cell Volume Kd value [LIP] pM [LIPH] pM [LIPDF0] pM
Parental cells 0.85 ± 0.006 28.82 ± 5.06 3.08 ± 0.59 2.93 ± 0.73 0 ± 0
H2O2 resistant 
cells
1.6 ± 0.19 20.06 ±2.51 3.34 ± 0.87 7.2 ±0.56 0 ± 0
Note: The LIP concentrations are expressed as mean ± SD (n=3-16). LIPH represents the LIP 
concentrations measured after 18h of 20pM hemin treatment in parental and H20 2 resistant Jurkat 
cells. LEPdfo represents the LIP concentrations measured after 18 h of 100 pM DFO treatment in 
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Figure 3.13: Effect of H20 2 on the survival of parental (A) and H20 2 resistant (B), Jurkat cells with or without 
hemin treatment. Both cell lines were treated with 20 pM hemin for 18 h prior to H20 2 treatment. In both cell 
lines MTT assay was performed 4 h following H20 2 treatment.
Mean ± SD (n=3)
*: p  < 0.05, significant difference between H20 2 treated and H20 2 + hemin treated, in parental cells 
t  : p  < 0.05, significant difference between H20 2 treated and H20 2 + hemin treated, in H20 2 resistant cells
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H2O2, the percentage o f cell survival in H2O2 + hemin treated cells was significantly 
higher than the H2O2 treated cells alone. In contrast in the H2O2 resistant cells the 
effects were exactly the opposite (i.e. the percentage o f cell survival in H2O2 + hemin 
treated cells were lower than the H2O2 treated cells alone). At the 24 h post-treatment 
time points both MTT and flow cytometric analyses showed (Figure 3.14) that the 
percentage of live cells in H2O2 + hemin treated cells was still higher in parental cells, 
but not in H2O2 resistant cells. Taken together, these results indicated that hemin 
treatment on the one hand protects parental cells against H2O2 treatment and on the 
other hand sensitises H2O2 resistant cells to H2O2 treatment.
We also evaluated the effect o f hemin on cell survival following UVA radiation of 
both parental and H2O2 resistant cell lines. For this purpose cells were first incubated 
for 18 h with 20 |iM hemin and then irradiated with UVA doses o f 100, 250 and 500 
kJ/m2. The MTT and flow cytometric assays were performed 4 and 24 h following 
UVA irradiation o f both cell lines. The analyses performed 4 h following UVA 
irradiation (Figure 3.11) demonstrated that hemin pre-treatment did not affect cell 
survival in either o f the cell lines. However, at 24 h post-treatmet time point, the 
percentage o f live cells dropped dramatically in both UVA treated parental and H2O2 
resistant cells (Figure 3.12), consistent with the notion that cells resistant to H2O2 are 
not necessarily resistant to UVA radiation. The percentage o f live cells was higher in 
hemin pre-treated cells when compared to UVA irradiated cells alone. So, it appears 







[H20 2] + 20pM  hem in
120
100
0 0.5 1 1.5 2 2.5 3
H 2O 2 [m M ]
[H2o 2]







2.50 0.5 1 1.5 2 3
B-2.
[H20 2]






0 0.5 2.51.5 2 3
H20 2 [m M ]  
 [H2o 2]




o 40  -
0 0.5 1.5 2 2.5 3
H20 2 [m M ] H20 2 [m M ]
Figure 3.14: Effect o f H20 2 on the survival of parental (A-1 and B-1) and H20 2 resistant (A-2 and B-2) Jurkat 
cells with or without hemin treatment. Both cell lines were treated with 20 pM hemin for 18 h prior to H20 2 
treatment. In both cell lines MTT assay (A-1 and A-2) and Flow Cytometry (B-1 and B-2) were performed 24 h 
following H20 2 treatment.
Mean ± SD (n=3)
* : p  < 0.05, significant difference between H20 2 treated and H20 2 + hemin treated, in parental cells 
t  : p  < 0.05, significant difference between H20 2 treated and H20 2 + hemin treated, in H20 2 resistant cells
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3.5.4 Effects o f iron loading on H?Q? mediated LIP release
In order to explain the differential effects o f hemin after H2O2 treatment between 
parental and H2O2 resistant cells, the LIP levels were measured immediately after 
H2O2 treatment. As shown in Table 3.5, the basal LIP levels, after 18 h hemin 
treatment, were up to 2.5 fold higher in H2O2 resistant cells (7.2 ± 0.56 jliM) as 
compared to parental cells (2.93 ± 0.73 p,M). Following H2O2 treatment LIP release 
occurred only in H2O2 resistant cells, while in parental cells the LIP level was not 
significantly different from the basal levels (Figure 3.15). Indeed, when H2O2 
resistant cells were treated with 50 |iM H2O2, the LIP level increased up to 4 fold 
when compared to untreated control cells. However at higher doses (i.e. 100 and 500 
jiM H2O2) the LIP release occurred to a lesser extent. Figure 3.16 shows the level of 
H202-mediated LIP release in each cell line with or without hemin pre-treatment. It 
appears that hemin pre-treatment decreases dramatically the level of oxidant-induced 
LIP release in the parental cell line. On the other hand the same pre-treatment boosts 
up to several fold the level o f H202-induced LIP release in H202-resistant cells. The 
latter results show a direct correlation between the extent of LIP release in both cell 
lines and the level of resistance of cells to H2O2.
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Figure 3.15: Effect of H20 2 on the concentration of labile iron pool in both parental and H20 2 resistant Jurkat 
cells with or without hemin treatment. Both cell lines were treated with 20 pM hemin for 18 h prior to H20 2 
treatment. The Calcein assay was performed immediately after H20 2 treatment.
Mean ± SD (n =3-6)
* : p<0.05, significant difference between normal and H20 2 resistant cells, at corresponded H20 2 doses 
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Figure 3.16: Effect of H20 2 on the concentration of labile iron pool in both parental (A) and H20 2 resistant 
(B) Jurkat cells. Both cell lines were treated with 20 pM hemin for 18 h prior to H20 2 treatment. The Calcein 
assay was performed immediately after H20 2 treatment 
Mean ± SD (n =3-6)
* : p<0.05, significant difference between H20 2 alone and H20 2 + hemin, in parental cells 
|  : p<0.05, significant difference between H20 2 alone and H20 2 + hemin, in H20 2 resistant cells
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3.6 The role of Ferritin in response to oxidative stress
Several studies have linked the higher intracellular level o f Ft to higher resistance 
o f cells to oxidative damage (Lin and Girrotti, 1997; Applegate et al, 1995). In 
addition, studies by Epsztejn et al (1999) demonstrated that overexpression o f the H- 
Ft in murine erythroleukemia cell lines reduced the formation of ROS and protected 
cells against cellular damage by exposure to H2O2.
However, recently it has been shown that Ft might act as a pro-oxidant since both 
UVA (Pourzand et al, 1999) and H2O2 (unpublished data, this laboratory) could 
trigger the immediate and dose-dependent proteolytic degradation o f Ft molecules and 
release the iron. Furthermore, it appears that modulation o f the basal level o f Ft in 
cells could directly influence both the level o f oxidant-induced LIP release and 
increased susceptibility of cells to necrotic cell death (unpublished data, this 
laboratory).
We therefore measured the basal Ft levels in both parental and H2O2 resistant 
cells, using both ELISA (see section 2.8) and immunoprecipitation methods (see 
section 2.9).
The results o f Ft ELISA (Table 3.6) showed no significant difference in Ft levels 
between parental (77.16 ± 10.75) and H2O2 resistant cell lines (82.32 ± 16.39). 
However since the ELISA kit used in this study is known to reflect mostly the level of 
human L-Ft, we decided to monitor the level o f Ft with immunoprecipitation using a 
human polyclonal Ft antibody following metabolic labelling o f both cell lines with 
35S-methionine (see section 2.9), as this method is extremely sensitive for evaluation 
o f this large cytosolic protein (see Pourzand et al, 1999). For this purpose both 
parental and H2O2 resistant cells were first metabolically labelled with 35S-methionine 
and then treated with a dose o f either 250 kJ/m2 UVA or 500 jiM H2O2 followed by
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immunoprecipitation with a human polyclonal Ft antibody. From Figure 3.17 that 
shows two representative gels from three independent experiments, it can be observed 
that Ft basal level is higher in H2O2 resistant cells as compared to the parental cells. 
Furthermore in both cell lines immediately after UVA or H2O2 treatment, no change 
in the Ft levels is apparent.
3.6.1 The level o f Ft after FbO? ± Hemin ± DFO treatments
Several studies have shown that loading of cells with iron sources (e.g. hemin) can 
cause an increase in intracellular level o f Ft. It is also known that iron deprivation in 
the cells following treatment o f cells with an iron chelator (e.g. DFO) could 
significantly decrease the level o f Ft.
In the present study, we assessed the levels o f Ft in both parental and H2O2 
resistant cells following 2 and 18 h treatment with either hemin or DFO. The Ft levels 
were measured with both ELISA (see section 2.8) and immnuoprecipitation methods 
(see section 2.9). The Ferritin ELISA method (Table 3.7) demonstrated that in both 
cell lines, 2 h hemin treatment did not significantly increase the level o f Ft, while 
incubation o f cells for 18 h with hemin increased the Ft level up to 3 fold o f the 
control values in both cell lines. For DFO treatment, the 2 h treatment did not affect 
the level o f Ft in both cell lines. However following 18 h DFO treatment, the 
intracellular level o f Ft decreased up to 2.5 fold o f the control values in parental cells 
and up to 4 fold in H2O2 resistant cells. These results were also in agreement with the 
observations obtained from the immunopricipitation method (Figure 3.18). First, we 
confirmed that Ft basal levels are up to 2 fold higher in H2O2 resistant cells when 
compared to the parental cells. When both cell lines were treated with hemin for 18h, 
a 2 fold increase in Ft levels could be observed in both parental and H2O2 resistant
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cells. However, when both cells were treated with DFO Ft synthesis was inhibited in 
both cell lines.
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Table 3.6: Assessment of Ft concentration (ng ferritin/mg protein) in both parental and H2O2 resistant 
Jurkat cells using an ELISA kit.
[Ferritin] ng ferritin per mg protein Fold difference




Note: Mean ± SD (n = 3)
NS : p>0.05, no significant difference between parental and H20 2 resistant cells
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Figure 3.17: Effect o f  UVA or H2O2 on intracellular level o f Ft. 35S-labeled parental and 
H2O2 resistant cells were exposed or not (i.e. in A and ‘Control’ in B ) to either UVA (250 
kJ/m2) or H20 2 (500 jaM) and then immediately lysed and immunoprecipitated with human 
polyclonal Ft antibody. Both A and B are representative gels chosen from three independent 
experiments.
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Table 3.7: The effect of hemin or DFO treatment on Ft concentration in both parental and 
H2O2 resistant Jurkat cells as measured by an ELISA kit.
[Ferritin] ng ferritin per mg protein
Parental cells H2O2 resistant cells
Control 77.16 ±10.75 NS 82.32 ± 16.39
Hemin 2h 117.003 ±26.19 102.41 ±33.8
DFO 2h 87.598 ±15.23 77.985 ±21.12
Hemin i8h 243.59 ± 30.28 * 248.65 ± 37.79 *
DFO 18h 33.01 ±11.3* 18.815 ±8 .78*
Note: Both cell lines were treated with 100 pM DFO or 20 pM hemin for 2 and 18 h. the Ft level 
was assessed in cell lysates using the Ft ELISA kit.
Mean ± SD (n = 3)
NS : p>0.05, no significant difference between parental and H20 2 resistant cells 
* : p< 0.05, significant difference compared to untreated control
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Figure 3.18: Effect o f DFO or Hemin on intracellular level o f ferritin. 35S-labeled parental 
and H2O2 resistant cells were exposed or not to either DFO (100 pM) or Hemin (20 pM) and 
then immediately lysed and immunoprecipitated with human polyclonal Ft antibody. This is a 
representative gel chosen from three independent experiments.
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3.7 The role of HO-1 in resistance of cells to H 2O2
Much evidence was accumulated, both in vitro and in vivo, that HO-1 participates 
in cellular defence mechanisms against oxidative stress. Keyse and Tyrrell (1989) 
were the first to identify HO-1 as the 32kDa stress protein induced in human cells by 
a variety o f oxidising agents including UVA and H2O2. Further studies reported that 
UVA radiation and H2O2 induce strong transcriptional activation o f the HO-1 gene 
(Vile and Tyrrell, 1993) which eventually leads to a HO-1 dependent increase in Ft 
and a consequent decrease o f the pro-oxidant state o f the cells (Vile et al, 1994).
The differential response o f Jurkat cell lines to H2O2 cytotoxicity and labile iron 
release following hemin treatment, prompted us to investigate whether differences in 
expression/activity o f HO-1 could play a role in this phenomenon, since hemin is a 
known substrate o f the HO-1 enzyme.
3 .7.1 HO-1 expression at the protein level
The basal and hemin stimulated levels o f HO-1 expression was first assessed by 
western blotting (see section 2.10). For this purpose, parental and H2O2 resistant cells 
were incubated with 20 pM hemin for 2, 4, 6 , 8 , 12 and 18 h prior to analysis with 
western blotting using a polyclonal HO-1 antibody (see Chapter 2.10). The western 
blot shown in Figure 3.19 is a representative blot from four independent experiments. 
Although because o f cross hybridisation, these blots were not quite clean, we could 
still consistently observe that firstly the basal level o f HO-1 in H2O2 resistant cells 
was higher than in parental cells and that secondly following hemin treatment, a 
significant increase in HO-1 expression could only be seen in the parental cells 
(Figure 3.19). Furthermore in both cell lines, 18 h following hemin treatment, HO-1 
expression had returned to around control level.
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Figure 3.19: Time course of HO-1 expression following treatment of both parental and H2O2 
resistant cell lines with 20 pM hemin. Cells were treated with hemin for various times (lane 1-7) 
and then analysed by Western blotting using a polyclonal HO-1 antibody. Actin antibody was 
used as a marker of even loading. This is a representative blot chosen from four independent 
experiments.
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To confirm the results of the western blotting, the expression o f HO-1 in hemin 
treated cells was also followed by flow cytometry using a monoclonal HO-1 antibody. 
The results (Figure 3.20) revealed that the basal level o f HO-1 protein in H2O2 
resistant cells was up to 2 fold higher than in parental cells. The latter result was in 
agreement with the observation made in western blot analysis. Furthermore when both 
cell lines were treated with 20 pM hemin for various time points, a significant 
increase in HO-1 expression could only be observed in the parental cells around 2 and 
4 h following the treatment. Moreover, although the basal level o f HO-1 expression 
was higher in H2O2 resistant cells than in parental cells, following hemin treatment no 
significant increase was observed between the basal and hemin treated H2O2 resistant 
cells. These results are consistent with the observations made by the western blot 
analysis and clearly demonstrate the refractory response o f HO-1 expression to hemin 
treatment in H2O2 resistant cells.
In parallel to western blot/flow cytometric analyses, the kinetics o f labile iron 
release was also monitored in both cell lines following hemin treatment. The results 
(Figure 3.21) showed that in H2O2 resistant cells after hemin treatment, the extent of 
labile iron release was not only higher (up to 4 fold) but also sustained for a longer 
period than in parental cells. The higher basal level o f HO-1 in H2O2 resistant cells is 
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Figure 3.20 : Flow cytometric analysis o f relative increases in HO-1 expression in both parental and H2O2 resistant cells. Both cell 
lines were incubated with 20 pM hemin for different time points (2,4, 6 and 8 h) and then incubated with HO-1 monoclonal 
antibody as described in section 2.11. A, shows the control levels of both cell lines based on the isotype controls. The median values 
are provided in bold on the peak of the fluorogram. B and C show the shifts in fluorescence obtained at different time points of 
hemin treatment in the parental (B) and in H2O2 resistant (C) cells.
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Figure 3.21: Time course of change in LIP levels following teatment of both parental and H2O2 
resistant cells with 20 pM hemin. Cells were treated with hemin for various times (i.e. 0 to 18 h) 
and then the change in LIP was monitored by Calcein assay. Mean ± SD (n = 6 - 8)
* : p<0.05, significant difference between normal and H2O2 resistant cells, at corresponding time 
points
t  : p<0.05, significantly different from untreated control
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3.7.2 HO-1 expression at the transcriptional level
Since the transcriptional activation o f the ho-1 gene is recognised to be a marker 
o f oxidative stress in mammalian cells, we examined the levels o f accumulation o f ho- 
1 mRNAs in both parental and H2O2 resistant cells using both RT-PCR and the newly 
developed method o f real time PCR (Light Cycler).
Despite numerous attempts to optimise the RT-PCR conditions, we failed to 
obtain a visible band for ho-1 in the agarose gel for either parental or H2O2 resistant 
cells at both basal and treated levels. A representative gel is shown in Figure 3.22, in 
which RT-PCR was performed in both parental and H2O2 resistant cells 4 h following 
H2O2 treatment. To show that the PCR conditions and the amplification steps were 
optimum, the parallel amplification o f the ho-1 cDNA was used as a positive control 
(Figure 3.22, lane 6). Furthermore to demonstrate that the lack of amplification bands 
in the agarose gel was not due to RNA degradation that may affect the performance of 
RT-PCR, the cDNAs were also amplified with pactin primers. As shown in Figure 
3.22, Pactin amplification was consistent and successful for all the samples.
To analyse the level of ho-1 mRNA accumulation with a more sensitive method, 
an attempt was made to use the real time PCR technique using the DNA binding dye 
SYBR Green I (section 2.15) in the Roche Ltd developed Light Cycler amplifier. For 
this purpose, both parental and H2O2 resistant cells were treated with 500 pM H2O2 
and then analysed by real time PCR 2, 4, 6, 8 and 18 h following the treatment. The 
results (Figure 3.23) showed that firstly the basal level of ho-1 mRNA is 2 fold 
higher in H2O2 resistant cells than in parental cells. Furthermore, 2 h following H2O2 
treatment, the ho-1 cDNA levels increase up to 1.6 fold and then quickly returns to 
around control values from 4 h to 18 h post treatment time points. In the case of
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parental cells, there was no significant increase in ho-1 cDNA levels when monitored 
up to 18 h post treatment time.
To compare the response o f both cell lines to H2O2 following hemin treatment, the 
cells were also treated with 20 pM hemin prior to H2O2 treatment with a dose o f 500 
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Figure 3.22: Analysis of the amplified products o f RT-PCR in untreated control (Control) and 4 h 
following H2O2 treatment in both parental and H2O2 resistant cells. The PCR products were run on a 
2% agarose gel stained with ethidium bromide. Samples were either amplified with ho-1 or pactin 
primers giving products of at 242 bp and 346 bp, respectively. For Pactin analysis negative controls (-) 
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Figure 3.23: Analysis of the ho-1 and Pactin expression, using the Lilght Cycler. In A, both cell lines 
were treated with 500 pM H2O2 and incubated for 2, 4, 6, 8 and 18 h prior to the analysis. In B, both 
cell lines were treated overnight with 20 pM hemin and then exposed to 500 pM H2O2 and analysed 
2, 4, 6, 8 and 18 h following H2O2 treatment. The figures A and B represent the ratio of ho-l/pactin 
expression as calculated using the standard curve analysis (section 2.15).
Mean ± SD (n = 4)
No significant difference was observed between parental and H2O2 resistant cells in both treatments.
3.8 The correlation between oxidative stress and MDR
3.8.1 Characterisation o f the expression o f mdr genes
Expression of the mdr-l gene has been shown to be associated with drug 
resistance. Studies on expression o f mdr-l mRNA have indicated that the mdr-l gene 
encodes for the multidrug resistant transporter, PgP. An important study by Epsztejn 
et al (1999) indicated that overexpression of the H-Ft subunit in a murine erythroid 
leukaemia cell line can reduce the response o f cells to oxidative stress by 
downregulating the level o f the labile iron pool in the cells and inducing the MDR 
phenotype which involves increased levels o f mdrl mRNA and protein (PgP) as well 
as drug transport and drug toxicity.
To investigate whether there is a correlation between the increased resistance o f 
cells to H2O2 and the induction of the MDR phenotype, we performed a series o f RT- 
PCR reactions using specific primers designed to amplify the MDR-related specific 
genes mdr-1, mxr and mrp-1.
The study o f the expression o f mdr-l gene involved treatment o f both parental and 
H2O2 resistant cells with non-toxic doses o f vinblastin (50 nM) for various time points 
(6, 18 and 24 h), since vinblastin has been shown to significantly induce the increase 
in the mdr-l levels in various tumour cell lines. To ensure that both PCR conditions 
and the quality o f prepared RNA were optimum as positive controls, two different 
concentrations of mdr-l cDNA (2 and 5 |iM) were used. Furthermore the 
amplification o f samples with (3-actin primers was used to demonstrate the quality o f 
the prepared RNA and the lack o f RNA degradation in the samples. Also, the RT 
negative samples were amplified in parallel to check the presence o f any genomic 
contamination in the samples. The results (Figure 3.24) showed no detection o f the 
mdr-l gene either for the control or treated samples indicating that mdr-l gene
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expression is quite low in these cell lines and is unlikely to play a role in the increased 
resistance o f cells to H2O2.
In addition to m dr-l, the level of expression o f mrp-1 and mxr genes was also 
investigated by RT-PCR using cDNA samples obtained after treatment o f both cell 
lines with the non-toxic dose of 20 pM doxorubicin. The agarose gels (Figure 3.25 
and Figure 3.26) showed no detectable band for either the mrp (Figure 3.25) or mxr 
(Figure3.26) gene in either the control or the treated samples analysed. These results 
were similar to the data obtained with the mdr-l gene. Taken together these data 
strongly indicated that expression o f these MDR-related genes are quite low in these 
cell lines and therefore their involvement in the higher resistance of cells to H2O2 is 
unlikely.
However because the MDR-related genes are a growing family, it could be 
postulated that the above RT-PCR analyses is not broad enough to represent the entire 
MDR genes involved, as several new subfamily members have been recently 
identified for both mdr and mrp genes (Litman et al, 2000). Furthermore since the 
above analyses were performed at the transcriptional level, it was relevant to evaluate 
the expression of these genes at the protein level. However instead o f analysing all 
candidate proteins with specific antibodies, we focussed on achieving general 
information about the involvement of any possible MDR-related protein with efflux 
activity in increased resistant of cells to H2O2. To this regard, we performed a series 
of drug efflux assays in both parental and H2O2 resistant Jurkat T cell lines by flow 
cytometry using the fluorescent dye DiOC2(3) that has been shown to be a common 
substrate for the mammalian ABC transporter proteins involved in MDR phenomenon 
such as PgP, MRP and MXR.
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Figure 3.24: Analysis of the amplified products of RT-PCR in parental andPbC^ resistant cells 6, 18 
and 24 h following vinblastin treatment. The amplified samples were loaded on a 2% agarose gel 
stained with ethidium bromide. Samples were either amplified with either mdr-1 or Pactin primers 
giving products of at 157 bp and 346 bp, respectively. For pactin analysis negative controls (-) included 
no RT step and numbers 1 to 10 represent the samples as shown on the gel for mdr-1 detection. The 
mdr-1 cDNA was used as a positive control and as shown on the first-top gel 2 and 5 pM were initially 
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Figure 3.25: Analysis of the amplified products of RT-PCR in parental and H20 2 resistant cells 6, and 
18 h following treatment with doxorubicin. The amplified samples were loaded on a 2% agarose gel 
stained with ethidium bromide. Samples were amplified with either mrp or pactin primers giving 
products of at 295 bp and 346 bp, respectively. For Pactin analysis negative controls (-) included no RT 
step and numbers 1 to 5 represent the samples as shown on the gel for mrp detection of the doxorubicin 
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Figure 3.26: Analysis of the amplified products of RT-PCR in parental and H20 2 resistant cells 6 and 
18 h following treatment with doxorubicin. The amplified samples were loaded on a 2% agarose gel 
stained with ethidium bromide. Samples were either amplified with mxr primers giving product of 
1169 bp. The mxr cDNA was used as a positive control.
140
3.8.2 Efflux assay: Example o f PgP
The PgP has been widely described as a cationic pump that when overexpressed 
induces MDR phenotype in various cancer cell lines. In the present work, we analysed 
the possible mechanism underlying the role o f PgP function in the increased 
susceptibility o f both parental and H2O2 resistant cells to oxidative damage. In 
particular, we compared the results obtained between Jurkat T cell lines used in this 
thesis and a well-established cell model for MDR phenotype i.e. the parental CEM 
lymphoid cell line (CEM) and its MDR variant (CEM/VLB100). For this purpose the 
baseline fluorescence signal o f DiOC2(3) efflux and inhibition o f efflux by verapamil 
was compared to determine the level o f PgP efflux activity. Figure 3.27 represents 
the flow cytometric analysis o f the PgP function in the CEM cell lines. These data 
clearly demonstrate an active efflux o f the PgP pump in the CEM/VLB100 cells at both 
30 and 90 min of incubation time points, while in the CEM cells, no increase is 
observed in the fluorescence signal after the addition o f the PgP inhibitor, verapamil, 
in agreement with observations made by other studies (Feller et al, 1996; 
Ganeshaguru et al, 2002). Interestingly in both Jurkat T cell lines (Figure 3.28) there 
was no increase in the fluorescence after the addition o f verapamil indicating that 
there is no PgP surface expression either at 30 or 90 min of incubation.
Finally, the fact that the Jurkat T cell lines retain the fluorescence dye DiOC2(3) 
as efficiently as parental CEM cell line, strongly suggests that none o f the suspected 
MDR proteins are overexpressed in these cells. In other words, it appears that the 
higher resistance of H2O2 resistant Jurkat T cell line to H202 is not linked to the 
development o f MDR phenomenon in these cells.
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Figure 3.27: Modulation of efflux of the dye DiOC2(3) by verapamil in both CEM (A) and CEM/VLBjoo (B) 
cell lines. Analysis was performed after 30 and 90 min of DiOC2(3) dye loading in the presence or absence of 
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Figure 3.28: Modulation of efflux of the dye DiOC2(3) by verapamil in both parental (A) and H2O2 resistant (EF 
cells lines. Analysis was performed after 30 and 90 min of DiOC2(3) dye loading in the presence or absence of 





Exposure to ROS is a common threat in mammalian cells. Oxidative stress occurs 
under circumstances where the amount of oxidants exceed a certain threshold level 
leading to the induction of oxidative damage. Recent studies in this field clearly 
demonstrate that the response of cells to either an acute (single high dose) or chronic 
(repeated low doses) exposures to oxidizing agents is quite different. Indeed it has been 
shown that chronic exposure of cells to low doses of oxidants provokes the development 
of an adaptive response in cells as a result of induction of a series of intracellular 
antioxidant pathways that differs quite sharply from that of acute exposure. The adaptive 
response triggered by chronic exposures allows the cells to withstand high toxic doses of 
the oxidizing agent that would otherwise be lethal to the cells.
Recently a number of studies have provided evidence for a possible link between the 
resistance of cells to high toxic concentrations of oxidising agents (such as H2O2) and the 
development of MDR phenotype (see Introduction, section 1.10). Most of these studies 
demonstrate that tumor cells that exhibit the MDR phenotype are also resistant to 
oxidizing agents such as H2O2 or UVA. However, to date no study has investigated 
whether adaptation of cells to high doses of oxidising agent would induce the MDR
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phenotype. Moreover there are studies that link the overexpression of H- or L-Ft in cells 
both to the development of MDR phenotype and to the higher resistance of cells to 
oxidising agent. However, to date no study has verified whether cells exhibiting 
resistance to oxidative stress would necessarily possess higher levels of expression of Ft 
and MDR-related proteins.
To answer these questions, in the present study, we used a cell model of parental and 
H2O2 resistant Jurkat T cell lines. Our investigation involved the characterisation of these 
cell lines in terms of intracellular anti-oxidant defence mechanism by comparing the level 
of expression of catalase, GSH-Px, GSH, Ft and HO-1 between parental and H2O2 
resistant cells. Furthermore, the role of labile iron and heme in modulating the resistance 
of cells to H2O2 was investigated. To investigate the possible link between the 
development of MDR phenotype and resistance to oxidative stress, the expression of key 
MDR-related genes were also monitored and compared between the two cell lines.
The role of antioxidant molecules/enzvmes:
It is assumed that high antioxidant status of the cell prevents H2O2 from travelling far 
through the cell. Under most circumstances, cellular antioxidant systems remove H2O2 
efficiently. Since catalase, GPx and GSH could detoxify H2O2 within the cells, we 
hypothesised that these enzymes/molecules could also contribute to the protective 
responses of H2O2 resistant cells against oxidative stress. Our results clearly 
demonstrated that GPx activity is significantly higher in H2O2 resistant cells than in 
parental cells. Furthermore, it was found that the basal level concentration of GSH is also 
considerably higher in H2O2 resistant cells compared to parental cell line. These data
145
strongly suggest that both higher GPx activity and GSH levels could be part of the 
adaptive response of cells that contribute to higher resistance of cells to H2O2. However 
catalase appears to play a minor role in this response. One explanation for the relative 
importance of GPx and GSH and not of catalase in the resistance of cells to H2O2 may be 
due to their intracellular location. Catalase enzyme is located in peroxisomes and its 
access to cytosolic H2O2 is limited. However GPx, unlike catalase, is mainly present in 
the cytosol and requires GSH to complete the catalytic cycle so it is likely that in H2O2 
resistant cells, H2O2 is reduced at higher levels by GPx than catalase.
The role of labile iron in increased susceptibility of cells to necrotic cell death:
Although several studies have shown that iron loading could sensitise cells to iron- 
mediated oxidative damage, little is known about how ‘basal’ intracellular LIP levels 
could influence the natural sensitivity of cells to oxidants. Recent unpublished data from 
this laboratory provide a strong link between the basal intracellular level of LIP in skin 
cells and the susceptibility of cells to UVA radiation. Accordingly, modulation of the 
basal or ‘UVA-induced’ levels of LIP appears to directly influence the extent of necrotic 
cell death in skin cells (unpublished data, this laboratory). In the present study it was 
found that necrosis is the predominant mode of cell death induced by H2O2 and UVA in 
both cell lines, as monitored by both Annexin V/PI and Apoglow assays. However, the 
H2O2 resistant cell line was considerably more resistant to H202-mediated necrotic cell 
death than the parental cell line.
Since H2O2 is also known to trigger the immediate release of labile iron, it was 
relevant in this study to investigate whether adaptation of H2O2 resistant cells to a high
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concentration of H2O2 would influence this phenomenon. The results demonstrated that 
although the basal level of LIP in both parental and H2O2 resistant cell lines is similar, the 
fLCVmediated release of iron in H2O2 resistant cells occurs to a lesser extent than in 
parental cell line. Furthermore, the lower level of labile iron release following H2O2 
treatment of H2O2 resistant cell line was coinciding with the lower level of necrotic cell 
death in this cell line. Taken together these findings strongly suggest that cellular 
resistance to H2O2 is tightly associated to intracellular level of LIP and that the “induced” 
rather than the “basal” level might be responsible for the increased susceptibility of cells 
to oxidative stress.
Interestingly, the exposure of both parental and H2O2 resistant cells to UVA 
promoted: a) similar levels of labile iron release and b) percentage survival, consistent 
with the notion that H2O2 and UVA may exert their effect on cells via different oxidative 
mechanisms.
To study to what extent the intracellular LIP level plays a role in the resistance of 
cells to H2O2, both cell lines were incubated with DFO (iron chelation) for 18 h prior to 
H2O2 treatment. DFO as an iron chelator is known to deplete intracellular iron levels by 
either inhibiting Ft synthesis via IRP or by stimulating Ft degradation, consequently 
preventing oxidative stress (Konijn et al, 1999). Previous findings by Lin and Girroti 
(1993) have identified intracellular level of ‘redox active iron’ as an endogenous pro­
oxidant and demonstrated that chelation of iron with DFO could significantly protect the 
leukemic cells against Merocyanine 540-mediated oxidative damage. Treatment with 
DFO has also been shown to completely abolish the UVA-induced LIP release in skin 
cells, thereby protecting the cells against both mitochondrial membrane damage and
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necrotic cell death (unpublished data, this laboratory). In the present study, DFO 
treatment of normal and H2O2 resistant cells protected cells against H2O2- and UVA- 
mediated damage. These findings are also supported by the assessment of LIP levels in 
both parental and H2O2 resistant cells that showed that DFO completely abolishes both 
the ‘basal’ and ‘induced’ level of LIP. Depletion of LIP levels in both cell lines is also 
consistent with the decrease in Ft levels, indicating that DFO operates by inhibiting Ft 
synthesis and therefore protects both parental and H2O2 resistant cells against oxidative 
damage. Finally our findings are entirely in agreement with the studies reporting that 
DFO protects cells against the cytotoxic effects of various oxidising agents (see 
Introduction, section 1.7).
The source of labile iron release in FLO^-treated Jurkat cell lines
In 1999, Pourzand et al clearly demonstrated that the UVA-induced increase in labile 
iron originates mainly from an “early” degradation of Ft in combination with 
“intermediate” HO-1-mediated heme breakdown. Accordingly, in vivo studies by Cairo 
and co-workers (Cairo et al, 1995; Tacchini et al, 1997) have also indicated that oxidative 
stress down regulates IRP and expands the level of free iron presumably via early 
proteolysis of Ft and ‘intermediate’ HO-1 mediated heme breakdown in rat livers. 
Furthermore, Hentze and Pantopoulos (1995) demonstrated that H2O2 treatment of 
cultured murine fibroblasts inhibited Ft synthesis as monitored by immunoprecipitation 
assay. However, in the present study we failed to demonstrate the early modulation of Ft 
by H2O2 in both cell lines. The lack of Ft degradation in these cell lines raises the 
question as to the source of the labile iron release following H2O2 treatment of cells.
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Much experimental evidence has indicated that there are other potential sources of iron 
responsible for the increased labile iron release. One such source is the heme that is 
released from microsomal hemoproteins immediately after UVA or H2O2 treatment of 
human skin fibroblasts (Kvam et al, 1999). In addressing this issue, Balia et al (1992) 
showed that hemin (lh  treatment) made cells more sensitive to lethal effects of H2O2 and 
this sensitivity decreased when cells were challenged with hemin for longer time (16-20 
h) since cells appeared to develop enhanced resistance to oxidants. Furthermore recent 
studies from this laboratory using an HO overexpressing cell line have demonstrated that 
the release of labile iron from heme via HO can cause transient hypersensitivity to 
oxidative UVA radiation (Kvam et al, 2000). Additionally, unpublished data from this 
laboratory provide strong evidence that hemin treatment of cells prior to UVA radiation 
could dramatically increase the level of UVA-induced labile iron release and the level of 
UVA-mediated necrosis (unpublished data). Interestingly, our current findings 
demonstrated that hemin pre-treatment increases on the one hand the resistance of 
parental cells to H202-induced necrotic cell death and on the other hand renders the H2O2 
resistant cells more sensitive to cytotoxic effect of H2O2. To investigate the differential 
effect of hemin prior to H2O2 treatment, the LIP levels were assessed. The data showed 
that hemin induces an increase in basal and H2C>2-induced LIP levels following H2O2 
treatment in H2O2 resistant cells but not in parental cells. These findings concur with the 
view that hemin increases the level of potentially harmful labile iron via heme oxygenase 
which in turn exacerbates the oxidative damage in cells leading to increased level of 
necrotic cell death in H2O2 resistant cells. This assumption is further strengthened by the 
observation that the basal level of HO-1 protein in H2O2 resistant cell line is two-fold
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higher than in parental cells and this should almost certainly contribute to higher rate of 
hemin breakdown and the consequent increase in both ‘basal’ and ‘H^C^-induced’ LIP in 
H2O2 resistant cell line.
It is well known that HO-1 is highly induced by oxidative stress in order to remove 
excess heme from the cell. Vile and Tyrrell (1993) have also reported that in human skin 
fibroblasts, an increase in Ft coupled with HO synthesis after UVA radiation, is directly 
linked to ROS formation, secondary to iron release by HO. It has also been shown by Lin 
and Girotti (1998) that hemin treatment results in elevated H-Ft levels in combination 
with an early increase in HO-1 levels. They concluded that most of the iron is sequestered 
in Ft that is being activated after HO-1 induction and thereby intracellular iron levels 
decrease and cells enhance hyperresistance to oxidising agents. In the present study we 
found that although HO-1 basal level is higher in H2O2 resistant cell line, the HO-1 is not 
induced following H2O2 or hemin treatment. This phenomenon that is known as 
refractoriness has also been previously observed in both human skin fibroblasts cells 
exposed to UVA irradiation 24-48 h following the first insult (Noel and Tyrrell, 1997) or 
in keratinocytes that possess higher basal HO activity but not inducible HO-1 expression 
(Applegate et al, 1995). Interestingly the refractoriness response of induced HO-1 
expression to re-induction has also been shown by hemin or a combination of hemin and 
H2O2 treatment (Noel and Tyrrell, 1997). Several studies have also shown that chronic 
exposure of cells to oxidizing insults could induce the HO-1 refractory response (Reeve 
and Domanski, 2002; McCourbey and Maines, 1994).
In addition to LIP, we have also investigated whether differences in Ft basal or 
induced levels might play a role in the differential susceptibility of cells to H2O2. Ferritin
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is an iron storage protein and it has alternatively been seen as a potentially harmful iron 
donor (Balia et al, 1992; Vile and Tyrrell, 1993; Vile et al, 1994; Lin and Girotti, 1998). 
Our results demonstrated that the basal level of Ft in H2O2 resistant cells is considerably 
higher than in parental cells and this should almost certainly contribute to the higher 
resistance of these cells to oxidative stress. The results obtained following hemin 
treatment further demonstrate that hemin induces Ft synthesis in both cell lines. However 
it appears that in parental cell line the Ft synthesis induction is mostly related to an HO-1 
coupled response whereas in H2O2 resistant cells, because of lack of induction of HO-1, 
the Ft induction is likely to occur mainly via IRP-1 regulatory response. Indeed because 
of higher accumulation of labile iron in H2O2 resistant cells following hemin treatment it 
is thought that IRP-1 downregulation would lead to induction of Ft synthesis. 
Furthermore, since in H2O2 resistant cells iron loading results in a constant increase in the 
LIP levels that remains stable even after H2O2 treatment, it is likely that downregulation 
of IRP-1 is also sustained for longer period leading to higher induction of Ft synthesis 
even if lacking the HO-1 coupled mechanism. This assumption is further strengthened by 
the observations made here that unlike previous studies with murine systems (see 
Introduction, section 1.7), the H2O2 treatment of Jurkat cell lines does not inhibit Ft 
synthesis but rather induces its synthesis. However, further investigations are needed to 
clarify the mechanism involved.
Figure 4.1 summarises the proposed mechanism for differential regulation of labile 
iron release between the parental and H2O2 resistant cells following hemin treatment. On 
the one hand, the results in the parental cells are in agreement with previous observations 
by Vile and Tyrrell (1993) that iron loading results in the early induction of HO-1
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activation as an emergency response to break-down heme and leads to HO-1-dependent 
increase in Ft and a consequent decreases of the pro-oxidant state of the cell. This 
contributes to the iron pool that is responsible for the increased Ft synthesis resulting in 
the decreased levels of intracellular LIP and protection of cell to oxidative damage. On 
the other hand, our findings in the H2O2 resistant cells shows, in agreement with previous 
work by Noel and Tyrrell (1997), that although these cells have higher basal levels of 
HO-1 as compared to the parental cells, iron loading promotes the early induction of Ft 
that is not dependent on the induction of HO-1.
In conclusion, the data presented here is the first observation of the direct association 
between intracellular level of LIP and the resistance of cells to oxidative damage. These 
findings highlight the crucial importance of the oxidant-induced labile iron release and 
the increased susceptibility of cells to oxidative damage.
The role of MDR in higher resistance of cells to H7O?
Further to our investigation on the reasons underlying cellular resistance to H2O2, an 
attempt was made to link the high H2O2 resistance of H2O2 resistant Jurkat cell line to the 
development of MDR phenotype in these cells as a result of overexpression of key MDR 
proteins. Our data indicated no link between MDR and resistance to H2O2, since both 
parental and H2O2 resistant cells appear to have similar drug efflux activity of PgP 
function and no genes responsible for the MDR phenotype (mdr-1, mrp and mxr) could 
be detected in either cell line.
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Figure 4.1: A proposed schematic model of the major differential events on parental 
and H20 2 resistant cells in respect to their differential sensitivity to oxidative damage.
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The significance of the current study
The present study highlights the importance of LIP in increased susceptibility of cells 
to oxidative stress and suggest potential pathways through iron chelation. Our findings 
also provide new insights into the mechanism of Ft induction by iron loading.
As chemotherapeutic agents eliminate tumor cells by inducing apoptosis in cancer 
cells via generation of ROS, much effort is now concentrated to elucidate the pathway by 
which some tumor cells develop antiapoptotic mechanisms to overcome the cell death 
induced by these agents. Our study should pioneer new approaches to increase the 
susceptibility of tumor cells to chemotherapy based on modulation of intracellular level 
of LIP. Furthermore, as higher basal level of Ft, HO-1 and GSH-Px all contribute to 
higher resistance of H2O2 resistant Jurkat cells to H2O2, anti-sense oligonucleotides 
therapy based on these antioxidant enzymes should provide an efficient mean to render 
the tumor cell lines more susceptible to chemotherapeutical agents.
Future projects
To gain further insight into the different mechanisms of iron regulation under 
conditions of oxidative stress, we have developed for the first time a cell line resistant to 
UVA radiation. This newly developed UVA resistant cell line is expected to help us 
understand to a greater extent the basis of cellular resistance to either UVA- or H2O2- 
mediated oxidative stress. Furthermore this cell line should provide further evidence on 
the correlation between iron and oxidative stress and should therefore help to identify the 
cascade of events that lead to oxidative damage.
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Regarding the MDR studies, we have already developed by clonogenic survival 
assays, cells resistant to vinblastine (PgP overexpression) and to doxorubicin (MRP 
overexpression). These cell lines need to be tested for their MDR properties and should 
be fully characterised in terms of ‘basal’ and ‘induced’ level of LIP under conditions of 
oxidative stress. These newly established cell line might provide more insights into the 
relation between oxidative stress/iron and MDR.
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